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INTRODUCTION 
 
 Thoracotomy is one of the most painful surgeries .  
Post thoracotomy pain leads to delayed recovery and 
contributes to postoperative morbidity in a highly 
significant manner
9
. Acute pain on the site of incision alters 
chest wall mechanics and impedes effective expansion of 
the chest, cough and ability to clear secretions predisposing 
the patients to delayed recovery, respiratory infection, 
ventilation perfusion mismatch and hypoxemia due to 
atelectasis
9
. Optimum pain relief after thoracotomy is 
necessary in order to reduce the incidence of  atelectasis and 
postoperative pneumonia
3
.  Epidural analgesia has emerged 
to be the gold standard analgesic technique for the 
management of postoperative pain after thoracotomy
19
.   
 
 It was Sicard and Cathelin who first reported epidural 
anaesthesia in 1901. Epidural needle was first introduced by 
Tuohy in 1945, which is widely used now. The first 
epidural catheter was introduced by Eugene Aburel. He 
used a ureteral catheter made of silk into the epidural spa ce 
for labour analgesia and in 1962, after several 
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modifications, the first polyvinyl catheter was introduced in 
the epidural space, thus facilitating continuous epidural 
block. Efficacy of adding opioids into the epidural space 
was first published by Behar et al in 1979 in the journal 
„The Lancet‟. Today, epidural has become a part of routine 
regimen for intra- and post- operative pain relief.  
 
 When an adjuvant like an opioid (fentanyl) is added to 
a local anaesthetic such as bupivacaine, its  concentration 
can be decreased to 0.125 % or even 0.0625% instead of 
0.5% or 0.25%. This would decrease the incidence of 
hypotension and unwanted motor blockade
16
.
 
 
 Dexmedetomidine is a highly selective newer 
prototype of α-2 agonists with α2:α1 selectivity of 
approximately 8 times more in comparison to clonidine
4
. 
Addition of dexmedetomidine to local anaesthetic provides 
early onset of sensory block, adequate sedation and a 
prolonged postoperative pain relief
14
. 
 
3 
 
 This study was undertaken to compare the effects of 
adding dexmedetomidine and fentanyl to epidural 
bupivacaine on post thoracotomy pain characteristics.  
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AIM OF THE STUDY  
 
1. To compare the duration and quality of post operative 
analgesia between fentanyl and dexmedetomidine  when 
added epidurally to bupivacaine in patients undergoing 
thoracotomy. 
2. To evaluate hemodynamic changes between the two 
groups, sedation and adverse effects, if any. 
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POST THORACOTOMY PAIN 
 
INTRODUCTION: 
 Thoracotomy requires a very painful, muscle splitting  
incision that is subject to continuous motion as the patient 
breathes. The reason for severe pain after thoracotomy is 
due to retraction, resection or fracture of ribs,  splitting of 
muscles like lattissimus dorsi, serratus anterior, pectoralis 
major and the intercostal muscles,  dislocation of 
costovertebral joints, irritation of pleura by intercostal 
drainage tubes and injury to intercostals nerves
(23)
.  
 
 Suboptimal management of pain after thoracotomy has 
major respiratory consequences
 (24)
. Inspiration is limited 
by pain, leading to reflex contraction of expiratory muscles, 
subsequently leading to decreased functional residual 
capacity, atelectasis, shunting and hypoxemia. Moreover, 
since deep breathing requires stretching of the incision site, 
patients without adequate pain relief try to prevent 
stretching of the incision by contracting their exp iratory 
muscles i.e., splinting, so as to limit the stretch occurring at 
the incision during inspiration.  This failure to take a deep 
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breath before exhaling forcefully results in ineffective 
cough leading to retention of secretions, atelectasis and 
pneumonia leading to respiratory failure. Other 
complications of inadequate pain relief include reduced 
mobility leading to deep vein thrombosis and pulmonary 
embolism.  Acute pain also leads to increased sympathetic 
tone causing increased after load and myocardial 
dysfunction and arrhythmia.  
 
ANALGESIC OPTIONS AVAILABLE: 
When no contraindication exists, central neuraxial or 
regional analgesia (epidural, intrathecal and paravertebral) 
is the technique of choice.  If contraindication is present 
due to anatomical difficulties or systemic or local infection 
then parenteral opioid infusion is the technique of choice.  
 
PARENTERAL OPIOIDS:  
Although reasonably good analgesia can be achieved 
by this technique, it is not usually the technique of choice 
as it can lead to respiratory depression and inhibition of 
cough reflex which is not favourable after thoracotomy. 
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Further,   immediately after surgery the patients are drowsy 
to use the PCA pump on their own.  
 
EPIDURAL ANALGESIA:   
It is considered to be the gold standard for pain 
management after thoracotomy. Usually the catheter is 
placed at the level of midpoint corresponding to the 
dermatome level of skin incision. The epidural drug is 
usually administered by a continuous infusion, patient 
controlled epidural analgesia (PCEA) or a combination of 
the two. The drawbacks include significant failure rate even 
in experienced hands and technical difficulty due to caudal 
angulations of the spinal process at the thoracic level.  
 
INTRATHECAL OPIOIDS:  
Preservative free opioids introduced into subarachnoid 
space produce  analgesia by moving cephalad to the site of 
injection depending on the baricity and volume,  strength 
and the nature of the opioid. Opioids with lower lipid 
solubility like morphine migrate cephalic  more readily 
before penetrating the spinal cord.  The delay in the onset 
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of analgesia after intrathecal injection is usually by 1 to 2 
hours.   
 
The drawback of using intrathecal opioid is usually 
sedation and respiratory depression due to excessive rostral 
spread.  All patients require monitoring for respiration and 
degree of sedation for at least 24 hours. Other side effects 
include pruritus, nausea and vomiting and urinary retention. 
 
PARAVERTEBRAL BLOCK: 
Paravertebral space is a wedge shaped area lateral to 
the intervertebral foramen and it communicates above and 
below with paravertebral spaces. The intercostal  nerve 
passes through the space without a facial sheath and hence 
reliably blocked with a local anaesthetic.  The term 
extrapleural blockade has been used synonymously with the 
paravertebral block as the nerve lies outside the parietal 
pleura. This technique can be used as a  single shot or as a 
continuous infusion with a catheter placed via a tuohy 
needle. Plain local anaesthetic solutions like bupivacaine 
0.25% is used at a rate of 10-15ml/hour. The advantage of 
this blockade is that the motor and sympathetic block  are 
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unilateral with less hypotension and better preserved 
respiratory function when compared to epidural blockade. 
 
INTERCOSTAL NERVE BLOCK: 
They are usually performed by single injections two or 
three intercostal spaces above and below the level of 
incision. They provide localized analgesia without any 
sympathetic blockade. It usually requires multiple 
injections and is usually short acting and the analgesia is 
inadequate posteriorly as the intercostal nerve gives off a 
branch posteriorly and the block is usually performed 
anterior to this. Local anaesthetic toxicity can be a problem 
as it usually requires multiple injections and large volume 
of local anaesthetic.  
 
INTERPLEURAL ANALGESIA: 
In this technique the local anaesthetic is usually 
injected between the parietal and visceral pleura either as a 
single bolus or as an infusion via indwelling catheter.  The 
disadvantage includes pooling of local anaesthetic in 
dependent position and loss of local anaesthetic via chest 
drain limiting effectiveness.  
10 
 
CRYOPROBE NEUROLYSIS: 
This technique involves application of  low 
temperature probe to intercostal  nerves to destroy them to 
provide long lasting analgesia up to 3 months until the 
nerves grow back by axonal regeneration. Complica tions 
include neuralgia and paresthesia and hence rarely used in 
practice now.  
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EPIDURAL BLOCK 
 
 Epidural blockade
5  
has a unique feature of segmental 
blockade where by only the desired segments required for 
analgesia are blocked, unlike the uncontrolled level of 
blockade which happens in spinal anaesthesia. The period 
of analgesia can be extended in the post-operative period 
through continuous catheters.  
 
 
ANATOMY OF EPIDURAL SPACE: 
Epidural space is an anatomical compartment in the 
vertebral column that extends from the base of the skull to 
the sacral hiatus, between the dural sheath and the spinal 
canal. In some areas it is a real space whereas in others it is 
a potential space.  
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The boundaries of the epidural space are as follows: 
 Superiorly - fusion of the spinal and periosteal layers of 
the dura mater at    the foramen magnum. 
 Inferiorly - sacrococcygeal membrane 
 Anteriorly - posterior longitudinal ligament, vertebral 
bodies and disc. 
 Laterally  - pedicles and intervertebral foramina. 
 Posteriorly - ligamentum flavum, capsule of facet joints 
and laminae. 
 
 The epidural space is most roomy at the upper 
thoracic levels. In adults the epidural space measures 
0.4mm at C7  –T1 region, 7.5mm in the upper thoracic 
region, 4.1mm at T11 – T12 region and 4 – 7mm in the 
lumbar region.      
 
CONTENTS OF EPIDURAL SPACE: 
Epidural space is a potential space filled with the fat, 
lymphatics, veins, and nerve roots that traverse it,  areolar 
tissue. It has no free fluid. 31 pairs of spinal nerves with 
their dural sleeves traverse the space and pass through the 
intervertebral foramina. 
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To reach the epidural space in mid sagittal plane, the 
following structures are penetrated by the epidural needle:  
 Skin and subcutaneous tissue  
 Supraspinous ligament  
 Interspinous ligament and  
 Ligamentum flavum. 
 
PHYSIOLOGICAL EFFECTS OF EPIDURAL BLOCKADE: 
 The physiologic effects of epidural block depend on 
the level of spinal segment which is blocked and also the 
number of spinal segments  being blocked. Usually,  epidural 
blocks given at higher thoracic levels and extensive 
epidural blocks covering a large number of spinal segments 
are associated with more sympathetic block. These have a  
more profound physiologic effect , especially in the 
cardiovascular system. 
 
CARDIOVASCULAR SYSTEM:  
 The effects on the heart and blood vessels depend on 
the level and the degree of sympathetic blockade. The 
cardiovascular effects of a block above T4 are the result of 
a high sympathetic block. The heart is supplied by 
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sympathetic fibres from T1  to T4. When these are blocked, 
cardiac contractility is decreased leading to bradycardia and 
profound hypotension
20
. In addition to these, a high 
thoracic epidural blockade also causes
21,22
 vasoconstriction 
of upper limbs and head and neck region and increased 
central venous pressure but there is no increase in stroke 
volume. Moreover secretion of catecholamines from the 
adrenal medulla is blocked due to splanchnic nerve 
blockade. Thus the normal compensatory mechanisms of a 
patient to decreased cardiac output are  lost in sympathetic 
blocks above T4.  
 
 Vascular smooth muscles are innervated by 
sympathetic fibres from T5 to L1 which maintain the 
vasomotor tone. Epidural block causes bilateral sympathetic 
blockade of these fibres, which cause venodilation with 
venous pooling of blood resulting in hypotension.  
 
RESPIRATORY SYSTEM: 
 Epidural blockade even up to thoracic levels have 
minimal effect on ventilation and oxygenation.  Major 
alteration in pulmonary function does not occur even with 
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abdominal or intercostal muscle para lysis by a high thoracic 
block. 
 
GASTROINTESTINAL SYSTEM: 
 Due to the blockade of the sympathetic splanchnic 
fibres from the T5 to L1 level, vagal action becomes 
unopposed, leading to an increase in bowel secretions, and 
an increased peristalsis causing a smaller , contracted gut. 
 
RENAL SYSTEM: 
 Epidural block has very little effect on renal function 
because the renal blood flow is usually maintained. Urinary 
retention may occur till the block wears off.  
 
NEUROENDOCRINE RESPONSE: 
 During the perioperative period, epidural block 
decreases the stress response to pain  by decreasing the 
release of stress hormones like epinephrine, nor 
epinephrine, vasopressin. 
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SIDE EFFECTS: 
Following are the side effects of epidural blockade : 
Due to physiological changes: 
 Hypotension 
 Bradycardia. 
Improper needle positioning: 
 Post dural puncture headache. 
 Inadvertent high spinal . 
 Others: 
 Hematoma. 
 Epidural abscess, Meningitis . 
 Allergy to local anaesthetics, local anaesthetic 
toxicity. 
 Anterior spinal artery syndrome. 
 Arachnoiditis and Transverse myelitis.  
 
CONTRAINDICATIONS:  
Absolute  
  Patient refusal.  
  Coagulopathy. 
  Skin infection at the injection site . 
17 
 
  Raised intracranial tension. 
  Uncorrected hypovolemia. 
 
Relative  
  Uncooperative patients . 
  Pre-existing neurological disorders . 
  Fixed cardiac output states .  
  Vertebral anomalies. 
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PHARMACOLOGY OF DEXMEDETOMIDINE  
 
 Dexmedetomidine is a selective α2 -receptor agonist 
with evidence of an increased ratio of α2 to α1 activity of 
1620:1, as compared to 220:1 when contrasted against 
clonidine .  The mechanism by which α2 -adrenergic receptor 
agonists produce analgesia and sedation is multifactorial.  
 
 Dexmedetomidine possesses analgesic properties and 
many other advantages and also lacks respiratory 
depression that may make it a useful and safe adjunct in 
diverse clinical applications.  
 
 Both hypnotic and supraspinal analgesic effects of 
dexmedetomidine are mediated by noradrenergic neurons, 
via hyperpolarisation of neurons.  
 
MECHANISM OF ACTION: 
1. Inhibition of nor epinephrine release and its associated 
activity in the descending medullo-spinal noradrenergic 
pathway. 
19 
 
2. Suppresses neuronal firing in the locus  ceruleus. 
Suppression of these inhibitory controls causes release of 
mediators and neurotransmitters that in turn decrease the 
secretion of histamine and produce hypnosis without any 
depression of ventilation.  
 
 In addition suppression of activity along the 
descending noradrenergic pathway terminates propagation 
of pain signals, resulting in analgesia or decreased 
awareness of noxious stimuli.  
 
 In neurons of the superficial dorsal horn  of the spinal 
cord, dexmedetomidine suppresses and reduces pa in 
transmission / conduction by:  
1. Inhibiting the release of glutamate and substance P from 
primary afferent terminals and 
2.  G - protein mediated activation of potassium channels 
causing hyperpolarisation of inter-spinal neurons. The 
stress response to surgery can be attenuated by 
sympatholytic effects caused by postsynaptic activation 
of central α2-recptors, leading to reductions in blood 
pressure and slowing of heart rate.  
20 
 
 Epidural dexmedetomidine exhibits synergism with 
local anaesthetics by prolonging the sensory/motor block 
duration time, postoperative analgesia and results in intense 
motor block without any additional morbidity.   
 
 Clinical studies exhibit potentiating of neuraxial local 
anaesthetics, decrease in intraoperative anaesthetic 
requirements with prevention of intraoperative awareness, 
improved intraoperative oxygenation and improved 
postoperative analgesia when epidural dexmedetomidine 
was used in conjunction with general anaes thesia. No 
neurological deficits have been reported till date in studies 
on both humans and animals during intrathecal / epidural 
use.  
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PHARMACOLOGY OF FENTANYL  
 
INTRODUCTION: 
 The chemical name of fentanyl is  N-(1-phenyl-4-
piperidyl) propionanilide. It is a structural analogue of 
meperidine. It is available as a citrate containing compound 
which does not require preservatives and is water soluble .  
One ml of fentanyl contains  50μg of fentanyl and 0.0785mg 
of citrate. The pka of fentanyl is 8.43. In the blood, 84% of 
the drug is bound to plasma protein . Fentanyl has a high 
lipophilicity with an octanol water partition coefficient of 
816 at physiologic pH compared with 1.4 for morphine. 
 
PHARMACOKINETICS OF NEURAXIAL ADMINISTRATION 
OF FENTANYL: 
 The actions of fentanyl in the epidural and intrathecal 
space have been well studied. After neuraxial 
administration it gets distributed in to the epidural space by 
moving across the meninges in to the CSF. Through the 
circulation of CSF it binds to the opioid  receptors which 
have been identified in the spinal cord. It migrates also to 
supraspinal sites via the CSF. Due to its high octanol – 
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buffer partition coefficient it has a high vascular 
permeability. So some amount of systemic absorption 
occurs through the spinal and epidural vessels and is 
directly proportional to the dose of bolus dose. Uptake into 
non specific binding sites such as  the epidural fat also 
occurs as it is lipophil ic. 
 
 Once it enters the CSF circulation, similar to other 
opioids, fentanyl spreads rostrally. At the level of cervical 
spine, the peak CSF concentration is reached within 20 
minutes compared to 3 hour for morphine. But the 
proportion of administered drug that migrates to the 
cervical region is small (10%) compared to morphine 
because of its high affinity to the non specific binding sites 
in the lipid rich spinal cord.  It has been postulated that 
fentanyl is less likely to produce clinically significant  
depression of ventilatory drive than morphine. Most suggest 
that fentanyl is associated with less number of adverse 
effects like sedation, pruritus, nausea, vomiting,  and 
urinary retention. 
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DOSE REQUIREMENTS: 
 The dosage recommendations for fentanyl  for repeated 
single bolus administration is 1-3µg/kg, up to 5µg/kg.  
Onset of analgesia occurs in 15 min and lasts 2 to 4 hour. 
 
SIDE EFFECTS:    
 The most common side effect with epidural fentanyl is 
pruritus with an incidence of 0-85%. The onset usually 
occurs within an hour of bolus epidural injection, is not 
associated with release of histamine,  and lasts 20-30min.  
The pruritus can be antagonised with naloxone 
administration. It is usually localised to the head and neck 
region and is of reduced intensity when compared to 
morphine. 
 
 There has been a 20 – 30% incidence of nausea and 
vomiting with epidural administration of fentanyl. Nausea 
typically occurs within 3 hours of administration of 
fentanyl.  
 
 Epidural opioids react with and block opioid receptors 
in the sacral portion of spinal cord. This blocks 
24 
 
parasympathetic sacral neural outflow and cause relaxation 
of detrusor muscle of urinary bladder. The maximum 
capacity of the urinary bladder is increased, leading to 
urinary retention. In most studies the incidence of urinary 
retention is less than 12% even though the reported 
incidence of urinary retention is from 0 -50%.  
 
 The most serious adverse effect of the use of epidural 
opioids is respiratory depression. Clinically significant 
respiratory depression can occur with either bolus doses o r 
continuous infusions of epidural fentanyl.  The ventilatory 
response of the patient in response to carbon dioxide 
accumulation is depressed after an epidural bolus dose of 
200µg.  However incidences of respiratory arrests and 
profound respiratory depression have been reported after a 
100µg dose. The overall incidence of clinically significant 
respiratory depression is approximately 1.8%.   
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PHARMACOLOGY OF BUPIVACAINE 
 
 Bupivacaine is an amide local anaesthetic agent.  It 
belongs to the homologous series of n-alkyl substituted 
pipecholyl xylidines.  It is produced for clinical use as a 
racemic mixture containing both „S‟ and  „R‟ forms in equal 
proportion. It is supplied as a hydrochloride salt . Its 
chemical name is 1-butyl-n-(2, 6-dimethyl phenyl) -2-
piperidine decarboxamide hydrochloride monohydrate.   
 
PHYSICO-CHEMICAL PROFILE
25
: 
Molecular weight  -  288 
pKa     - 8.1 
Plasma protein binding -  95% 
Partition coefficient  - 28 (lipid solubility)  
T ½     - 210 min 
Clearance    - 8.3 l/min 
 
MECHANISM OF ACTION: 
 Like all the other local anaesthetics, it inhibits Na+ 
channels.  It decreases or prevents large transient increase 
in permeability of the cell membranes to Na ions that 
26 
 
follows depolarization of the membrane and thereby blocks 
the nerve conduction.  It also reduces the permeability of 
the resting nerve membrane to potassium ions as well as 
sodium ions and hence has got a stabilising action on all 
excitable membranes. 
 
CLINICAL EFFECTS: 
Local  – nerve blockade 
Regional  – pain, temperature, touch, motor power and 
vasomotor tone supplied by the nerves are blocked.  
Systemic  – effects due to systemic absorption or accidental 
intravenous administration.  
 It is 4 times more potent than lignocaine but the onset 
of action is slower.  The duration of action is longer.  
Sensory block is more marked than the motor block.  
 
SYSTEMIC EFFECTS: 
CNS: 
 Circumoral numbness, metallic taste  
 Tinnitus, light headedness, dizziness  
 Confusion, slurred speech 
 convulsions 
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CVS:  
 Depresses automaticity and contractility of the heart . 
 Slows conduction of cardiac action potential and 
prolongation of PR and QR intervals on ECG.  
 Re-entrant phenomenon and ventricular arrhythmias . 
 R-enantiomer is more toxic than S-enantiomer 
 Pregnancy increases cardiotoxic effects of 
bupivacaine 
PHARMACOKINETICS: 
 Rapidly absorbed from the site of injection  
 Peak systemic concentration – 5 to 30 minutes after 
administration 
 Metabolism in liver – dealkylation to 
pipecoloxylidine, aromatic hydroxylation 
 Excretion – 5% by kidney as unchanged drug and rest 
as metabolites 
CONTRAINDICATIONS: 
 Known hypersensitivity to amide local anaesthetics  
 Intravenous regional anaesthesia(IVRA)  
MAXIMAL DOSE: 
28 
 
 2.5 mg/kg body weight and the strength used is  0.25 – 
0.75% with or without adrenaline (1:200000 or 1:400000)
25
.  
Adrenaline does not prolong its effect, but reduces its 
toxicity. 
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REVIEW OF LITERATURE  
 
1. Sukhminder Jit Singh Bajwa et al
1
 did a study to 
compare the effects of dexmedetomidine and fentanyl for 
epidural analgesia in patients undergoing lower limb 
orthopaedic surgeries. They compared the effects of adding 
fentanyl and dexmedetomidine to epidurally administered 
ropivacaine on the hemodynamic status, analgesic and 
sedative effects.  They recruited hundred patients who 
underwent lower limb orthopaedic surgeries in the age 
group 21 -56 years of both gender belonging to ASA 1-2 
status. Patients were divided into two groups with 50 
patients in each group–GroupRD (Ropivacaine plus 
dexmedetomidine) and RF (Ropivacaine plus fentanyl). 
Ropivacaine. Drug was injected in both the groups at a dose 
of 15ml (0.75% ropivacaine) along with dexmedetomidine 
1µg/kg in the RD group and fentanyl 1µg/kg in the RF 
group.  The parameters studied included cardiorespiratory, 
block characteristics like time to onset of analgesia at T10, 
maximum sensory level , time to complete motor blockade, 
two segmental regression time and time to first rescue 
analgesia.  The demographic profile was comparable in both 
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the groups. Onset of sensory analgesia at T10  (7.12+2.44 vs 
9.14+2.94) and establishment of motor blockade 
(18.16+4.52 vs 22.98+4.78) was significantly earlier in the 
RD group.  The analgesia in the postoperative period was 
significantly prolonged in the RD group (366+24.42) when 
compared to the fentanyl group (242.16±23.86). The 
sedation scores were better with high incidence of dry 
mouth in the dexmedetomidine group. The incidence of 
nausea and vomiting were higher in the RF group.  They 
concluded that dexmedetomidine is a better epidural 
adjuvant when compared to fentanyl as it provided stable 
hemodynamics, early onset of sensory anaesthesia with 
prolonged postoperative analgesia and better sedation 
levels.  
 
2. M. Elhakim et al
2
 studied the effect of epidural 
dexmedetomidine on intraoperative awareness and 
postoperative pain after one lung ventilation.  They 
recruited 50 adult patients for the study. They were 
randomly assigned to receive either epidural 
dexmedetomidine 1µg/kg with bupivacaine 0.5% 30-40mg 
(group D) or bupivacaine (0.5%) 30- 40mg (group B) alone 
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after induction of general anaesthesia. Postoperatively pain 
was assessed using 11point verbal rating scale (VRS) and 
sedation was assessed using the inverted observers 
assessment of alertness/sedation scale (OAA/S). They 
showed that patients receiving dexmedetomidine required 
less supplementary fentanyl than patients in group B to 
maintain BIS values between 40 and 60. The verbal rating  
score was significantly lower in the dexmedetomidine group 
when compared with group B.  They concluded that the use 
of dexmedetomidine via epidural route during one lung 
ventilation significantly decreases the anaesthetic 
requirement preventing awareness during anaesthesia and 
improving intraoperative oxygenation and postoperative 
analgesia. 
 
3. S.V. Mohan et al
3
 studied the effect of thoracic epidural 
infusion for post thoracotomy pain by comparing fentanyl -
bupivacaine mixture with fentanyl alone. The study was 
conducted on 106 patients who were scheduled to undergo 
pulmonary resection.  Patients were allocated to three 
different groups namely group F, FB1 and FB2.  The group 
FB1 received infusion containing fentanyl 10µg/ml with 
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bupivacaine 0.1% and group FB2 received infusion 
containing fentanyl10µg/ml and bupivacaine 0.2% while the 
patients in group F received infusion of fentanyl10µg/ ml 
alone . They found no inter - group differences in OVRS 
(observer/ verbal ranking scale for pain ) at any time. At 2 
hours they found that the visual analogue scores while 
coughing were significantly higher in group F than group 
FB1 or FB2. Otherwise they found no differences in pain 
scores or in the total amounts of epidural solution used. 
There were no complaints of motor or sensory abnormalities 
by any patients in both the groups.  The number of patients 
who received interventions for hypotension included 3 
patients in groups F, 5 and 7 patients in group FB1 and FB2 
respectively.  The requirement for vasopressor was higher 
in the FB2 group. The number of patients who complained 
of nausea included 15, 9 and 12 respectively in groups F, 
FB1 and FB2 respectively.  The number of patients who 
complained of pruritus included 13, 15 and 14 in groups F, 
FB1 and FB2 respectively.  They concluded that in the early 
postoperative period 0.1% bupivacaine provides better 
analgesia with fentanyl in patients undergoing lung 
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resection and is not associated with any disadvantages seen 
with bupivacaine 0.2%. 
 
4. Jain D et al
4
 studied the effect of epidural 
dexmedetomidine with intrathecal bupivacaine on 
hemodynamic parameters and quality of analgesia in the 
perioperative period in patients undergoing elective lower 
limb orthopaedic surgery.  In this study 60 male patients 
between 20 – 50 years of ASA status 1 and 2 were 
recruited. They were randomly allocated to two groups . 
Group 1 received 2.5ml of 0.5%bupivacaine intrathecallly 
plus 10ml of normal saline epidurally whereas group 2 
received the same intrathecal bupivacaine dose with 
dexmedetomidine 2µg/kg made up to 10ml epidurally.  The 
results showed that the patients receiving epidural 
dexmedetomidine had a prolonged duration of analgesia of 
424.1minutes when compared to the control group 
(140.0min).  A significant fall  in the pulse rate and mean 
arterial pressure was noticed in group 2 patients at all 
intervals until the end of the period of study. However both 
heart rate and blood pressure remained within the 
physiological range at all time intervals in the 
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dexmedetomidine group. Sedation score was between 3 and 
4 in majority of the patients after 10-15min after 
administration of dexmedetomidine and lasted for 45±5 
min. They concluded that addition of dexmedetomidine 
prolongs the duration of analgesia, decreases the 
requirement of rescue analgesics with significant fall in 
pulse rate and mean arterial pressure in patients undergoing 
elective lower limb orthopaedic surgery.  
 
 5. Ashraf Amin et al
5
 studied the analgesic efficacy of 
dexmedetomidine in patients undergoing major abdominal 
cancer surgery.  Ninety patients were randomized into 3 
groups to receive either 10mg bupivacaine 0.5% 
intrathecally (control group n=30), or 10mg bupivacaine 
0.5% with dexmedetomidine 5µg (dexmedetomidine group 
n=30), or 10mg bupivacaine 0.5% with dexmedetomidine 
5µg and fentanyl 25µg (dexmedetomidine + fentanyl group 
n= 30). The patients were assessed for parameters like pain 
severity, first analgesic request time, total consumption of 
analgesics , hemodynamics, sedation score and side effects 
during the first 24 hours.   They noticed that the mean 
intraoperative heart rate was significantly lower in the 
35 
 
group of patients receiving dexmedetomidine when 
compared with the control group. Though there was a 
significant reduction in the mean intraoperative systolic and 
diastolic pressure in the patients receiving 
dexmedetomidine there was no difference between the 
groups on postoperative hemodynamics or seda tion score.  
The mean VAS values were significantly lower immediately 
and at 12 hours in both group of patients receiving 
dexmedetomidine compared to the control group. The mean 
time of the first analgesic request was significantly 
prolonged in the dexmedetomidine group (3.30±0.87  hours) 
and the dexmedetomidine+fentanyl group (5.41±1.23 hours) 
compared with the control group (0.23±0.11hours).  They 
also recorded that the postoperative tramadol consumption 
was significantly less in the dexmedetomidine group when 
compared to the control group. They found significant 
differences in pruritus and vomiting among groups whereas 
no difference was noted to the incidence of nausea among 
groups.  They concluded that providing dexmedetomidine 
intrathecally significantly improved the quality and 
duration of analgesia with analgesic sparing effect in 
patients undergoing major abdominal cancer surgery. 
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6. Saadawy et al
6
 studied the effect of dexmedetomidine on 
the caudal block characteristics of bupivacaine in pediatric 
patients. Sixty children of ASA grade 1 aged between 1 to 6 
years undergoing unilateral inguinal hernia repair 
/orchidopexy were recruited for the study. They were 
randomly allocated to two groups with 30 children in each 
group. Group B received a caudal injection of bupivacaine 
0.25%, 1ml/kg; whereas the group BD received the same 
dose of bupivacaine mixed with dexmedetomidine 1µg/kg 
during sevoflurane anaesthesia.  The parameters recorded 
included heart rate, blood pressure, pulse oximetry, end -
tidal sevoflurane and bispectral index score every 5 
minutes. Postoperatively the parameters recorded included 
emergence characteristics, pain  and sedation score and 
quality of sleep.  Duration of analgesia and requirement for 
additional analgesics was noted. It was found that the 
anaesthetic requirements in terms of end tidal sevoflurane 
concentration required to maintain target BIS level was 
significantly lower in the BD group compared with the B 
group. It was also found that the incidence of agitation was 
significantly lower in the dexmedetomidine group. The time 
to first rescue analgesic dose was significantly longer in the 
37 
 
BD group (18.5±2.8h) when compared to the B group 
(6.2±2.8h). There was no significant hemodynamic 
instability in any of the patients during the postoperative 
period.  The maximal decrease in heart rate was 38±8 
beats/min in the dexmedetomidine group which occurred at 
mean times of 28±7 min.  The mean duration of sedation 
was significantly prolonged in the dexmedetomidine group. 
They concluded that addition of dexmedetomidine to 
bupivacaine improved the caudal analgesia with fewer 
requirements for postoperative analgesics and with minimal 
respiratory and hemodynamic depression.  
 
7. A.M.El-Hennawy et al
7
 studied the effect of adding 
clonidine or dexmedetomidine to bupivacine for caudal 
analgesia in children. Sixty patients in the age groups of 6 
months to 6 years were recruited for this study.  The 
children received single caudal dose of bupivacaine 0.25% 
(1ml/kg) combined with either dexmedetomidine 2µ/kg in 
normal saline 1ml (Group A) or clonidine 2 µg/kg in normal 
saline 1 ml (Group B) or corresponding volume of normal 
saline (Group C) according to the group assigned after 
sevoflurane in oxygen anaesthesia. Postoperative analgesia , 
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rescue analgesia and side effects were assessed during the 
first 24 hour period.  The postoperative analgesia time 
recorded a median of 5 hours compared with 16 and 12 
hours in group A and B respectively. No clinically 
significant episodes of hypotension, bradycardia or 
respiratory depression were observed in the postoperative 
period. They concluded that addition of dexmedetomidine 
or clonidine to caudal bupivacaine in children undergoing 
elective lower abdominal surgeries significantly promoted 
analgesia. They also concluded that dexmedetomidine did 
not offer any advantage over clonidine with regard to the 
duration of analgesia in the postoperative period.  
 
8. Hazem M. Fawzi et al
8
 studied the effect of preemptive 
caudal dexmedetomidine –bupivacaine mixture following 
single level lumbar laminectomy in adult patients.  The 
study was conducted in 50 adult ASA 1 and 2 patients 
undergoing elective single level lumbar hemipartial 
laminectomy.  Group B (n=25) received caudal 20ml of 
isobaric bupivacaine 0.25% while group BD (n=25) 
received the same volume of isobaric bupivacaine with 
dexmedetomidine 1µg/kg.  Hemodynamic changes, end tidal 
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sevoflurane, BIS, narcotic requirement intra and post 
operatively, PCA boluses, sedation score and time to first 
void were all recorded. It was found that there were no 
significant hemodynamic differences  between the groups 
except for bradycardia in the group BD intra and 
postoperatively until 8 hours. The time to first rescue 
analgesia was longer in group BD (495.200±95.224) when 
compared to the group B (262.0±22.913).  The other 
advantages of group BD included less fentanyl 
supplementation, lower BIS and less end tidal sevoflurane 
requirements intraoperatively.  They concluded that 
dexmedetomidine supplementation lead to better analgesia, 
less analgesia supplementation together with lower 
intraoperative BIS.  
  
9. Staffan Wahlander et al
9  
studied the effect of 
intravenous dexmedetomidine as an adjunct to thoracic 
epidural analgesia with bupivacaine following thoracic 
surgery. They hypothesized that supplementation of low 
dose thoracic epidural bupivacaine infusion by intravenous 
dexmedetomidine will lower the analgesic requirement 
without causing any respiratory depression.  Twenty eight 
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patients who were scheduled to undergo elective 
thoracotomy for lobectomy or pneumonectomy were 
recruited for the study. The patients were loaded with 
bupivacaine 0.125% to T4 sensory level followed by a 
continuous infusion of 0.125% bupivacaine without opioid 
at 4ml/hour.  The patients were then randomized into two 
groups. The dexmedetomidine group received a continuous 
i.v. infusion of 0.4µg/kg/hour following a bolus dose of 
0.5µg/kg over 20 minutes.  The analgesic requirement was 
measured by VAS and PCEA dosing and other additional 
analgesic use was recorded. They found no significant 
difference between the groups in terms of VAS score and 
PCEA use. They noticed that the requirement for 
supplemental fentanyl was greater in the placebo group. 
The patients belonging to the dexmedetomidine group also 
had decreased heart rate and blood pressure when compared 
to the placebo group.  They concluded that i .v. 
dexmedetomidine can be used as an effective analgesic 
adjunct to thoracic epidural bupivacaine infusion which can 
decrease the opioid requirement and the potential for 
respiratory depression.  
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10. Mario Concha et al
10
 compared epidural 
fentanyl/bupivacaine with intercostal nerve block with 
intravenous morphine for analgesia after thoracotomy. They 
compared the quality of analgesia and lung function in two 
groups of patients undergoing posterolateral thoracotomy. 
The patients in group 1 (n=16) received a 5 segment 
intercostal block plus i.v. PCA morphine and group 2 
patients (n=15) received fentanyl and bupivacaine infusion 
for analgesia. They found that the patients in group 2 had 
lower resting and dynamic scores but only the resting 
scores were statistically significant. They showed that since 
the difference in pain scores is not clinically significant 
intercostal blockade with bupivacaine plus i .v. morphine 
PCA is a good alternative for post  thoracotomy pain 
management.  
 
11. Arjunan Ganesh et al
11
 studied the efficacy of adding 
fentanyl to bupivacaine epidural infusion for postoperative 
analgesia in infants undergoing thoracotomy for lung 
resection.  They recruited 32 infants randomly to receive 
either 0.1% bupivacaine infusion (group B, n=16) or 0.1% 
bupivacaine with 2µg/ml fentanyl (group BF, n=16) . 
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Patients were evaluated for a period of 24 hours for pain, 
time to first rescue analgesia and complications.  The 
rescue doses were given by intravenous nalbuphine. They 
noticed that the pain scores and nalbuphine consumption 
were significantly decreased in the group BF compared to 
group B.  The time to first rescue analgesia was 
significantly longer in the group BF (516±524min) than in 
group B (126±89min).  They noticed that incidence of side 
effects and the time to discharge and the time to first 
successful feeding were similar in both the groups.  
 
12. M. Licker et al
12
 studied the influence of thoracic 
epidural analgesia on the autonomic control of 
cardiovascular functions after  thoracic surgery. They 
divided thirty eight patients into two groups to receive 
either patient controlled analgesia (PCA) or thoracic 
epidural analgesia (TEA) with bupivacaine (0.25% during 
operation, 0.125% after operation) and fentanyl (2µg/ml).  
The cardiovascular autonomic functions were assessed by 
heart rate variability, baroreflex function and pressure 
response to nitroglycerine and phenylephrine . They were 
assessed before surgery and 4 hours after the surgery and 
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during the first and second postoperative days.  They 
concluded that using low concentrations of bupivacaine and 
fentanyl blunted cardiac symphathetic neural drive resulting 
in vagal predominance and better restoration of heart rate 
variables when compared with PCA management.  
 
13. Constant et al
13  
studied the effect of adding clonidine 
or fentanyl to local anaesthetic on the duration of surgical 
analgesia in children undergoing single shot caudal block. 
They recruited 64 children between the age group 6 to 108 
months undergoing bilateral correction of vesicoureteral 
reflux lasting more than 90 minutes.  The children were 
allocated into four groups. Group O received bupivacaine 
(0.25%) with epinephrine and lidocaine (1%) in equal parts. 
Group F received the same mixture of local anaesthetics 
with fentanyl 1µg/kg, group C received the same mixture of 
local anaesthetics with clonidine 1.5µg/kg and group C+F 
received local anaesthetics with fentanyl 0.5µg/kg and 
clonidine 0.75µg/kg. It was found that the single shot of 
epidural was sufficient only in 57% of the children in group 
O compared with 93% in group C and F and 86% in group 
C+F. The time to the first administration of analgesic was 
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significantly longer in the three groups of children who 
received additives but there were not any differences among 
the groups who received additives. Vomiting was noticed in 
the fentanyl group and the clonidine group had added 
advantage as it did not produce clinically significant side 
effects.  
 
14. Sukhminder et al
14
 did a comparative evaluation of 
clonidine and dexmedetomidine in epidural anaesthesia.  
They recruited 50 female patients of ASA 1 and 2 in the age 
group of 44 and 65 years who underwent vaginal 
hysterectomies. The patients were allocated to two 
treatment groups RC (Ropivacaine and clonidine) and RD 
(Ropivacaine and dexmedetomidine) with 25 patients in  
each groups. Group RC was administered 17ml of 0.75% 
epidural ropivacaine and 2µg/kg of clonidine and group RD 
was administered 17ml of 0.75% ropivacaine and 1.5µg/kg 
of dexmedetomidine. The parameters assessed included 
onset of analgesia, sensory and motor block levels, 
sedation, duration of analgesia and side effects. They 
noticed earlier onset of sensory analgesia and modified 
bromage scale 3 with dexmedetomidne when compared to 
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clonidine. The sedation scores were also significantly 
higher in the dexmedetomidine group. The time to rescue 
analgesia was longer in the dexmedetomidine group 
(342.88±29.16) when compared to the clonidine group 
(310.76±23.76). The sedation scores were significantly 
better in the dexmedetomidine group. They noticed a little 
higher incidence of dry mouth and nausea in both the 
groups. They concluded that dexmedtomidine is a better 
neuraxial adjuvant as it provided early onset of analgesia , 
adequate analgesia and prolonged post - operative analgesia.  
 
15. Vijay G Anand et al
15  
conducted a randomized double 
blinded study to compare the effects of caudal 
dexmedetomidine when added to ropivacaine in 60 children 
undergoing lower abdominal surgeries. They were divided 
into group RD (n=30) who received 0.25% ropivacaine 
1ml/kg with dexmedetomidine 2µg/kg and group R who 
received 0.25% ropivacaine 1ml/kg with normal saline. The 
duration of postoperative analgesia was a median of 5.5 
hours in group R compared to 14.5 hours in group RD. They 
concluded that caudal dexmedetomidine (2µg/kg) with 
0.25% ropivacaine (1ml/kg) in paediatric lower abdominal 
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surgeries resulted in significant postoperative pain relief 
that resulted in a better quality of sleep and a prolonged 
duration of arousable sedation and produced less incidence 
of emergence agitation following sevoflurane anaesthesia.  
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MATERIALS AND METHODS 
 
 The present study was conducted after obtaining 
institutional ethical approval on adult patients admitted to 
Rajiv Gandhi Govt. General Hospital . The recommendations 
guiding medical doctors in biomedical research involving   
human subjects contained in the “eighteenth declaration of 
Helsinki” adopted by the world medical assembly, Helsinki, 
Finland, 1964 were adhered to throughout the study.  
 
INCLUSION CRITERIA:  
 Adult patients aged 18 – 60 years undergoing elective           
thoracotomy with ASA physical status II & III who have 
given valid informed   consent. 
 
EXCLUSION CRITERIA: 
 Patients younger than 18 years or older than 60 years.  
 Known allergy to bupivacaine or anaes thetic drugs. 
 Patients with deformities of vertebral column.  
 Patients with hepatic or renal insufficiencies.  
 Patients with neurological or psychiatric illness.  
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 Patients with coagulation disorders. 
 Patients with BMI > 35 Kg/m2 .  
 Patients with pre existing motor or sensory deficits.  
 Patients with predicted post operative fev1 < 40 %  
 
 Written consent was obtained from all the patients 
after explaining the procedure. For a ll patients age, weight 
and height were noted. In the assessment room, vital 
parameters like pulse rate, blood pressure and baseline 
investigations like hemoglobin, blood sugar, urea and 
creatinine, CXR and ECG were checked. Pulmonary 
function tests were done preoperatively in all patients. 
Thorough examination of all the systems and airway 
examination were done. Visual Analogue Scale (VAS) was 
explained to the patients. The patients were shown a 10 cm 
long scale marked from 0 – 10 on a blank paper and told 
that 0 represented “no pain” and 10 represented “worst 
possible pain”. 
 
MATERIALS USED: 
1. 16 G,  9 cm Touhy needle, with  Hueber‟s tip,  
2. 18 G epidural catheter, filter,  
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3. Loss Of Resistance syringe,  
4. 5 ml syringe, 
5. local anaesthetic preparation of 1.5 % lignocaine with 
1 in 2 lac adrenaline,  
6. Sterile drapes, 
7. Visual analogue scale 
 
DRUGS USED:  
 Bupivacaine  
 Fentanyl  
 Dexmedetomidine  
 
PARAMETERS STUDIED:   
Primary outcome measures: 
 Duration of analgesia :  The time interval from 
injection of epidural drug to rescue analgesia.  
 Quality of analgesia as assessed by visual analogue 
score. 
 Level of Sedation  as assessed by a five point sedation 
scale. 
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Secondary outcome measures:  
 Hemodynamic parameters  – variations in heart rate, 
systolic blood pressure, diastolic blood pressure, and 
mean arterial blood pressure. 
 Side effects – respiratory depression, pruritus, nausea 
and vomiting, dry mouth, if any. 
 
BRIEF PROCEDURE:    
 Fifty adult patients (18 – 60 years) undergoing 
elective thoracotomy and planned for epidural analgesia 
post operatively were included in this randomized double 
blinded study.  They were randomly allocated  to two 
groups; group D and group F.  Group allocation was done 
by closed envelope method. 
 
GROUP D: Received 8ml of 0.125% bupivacaine and 1µ/kg 
of dexmedetomidine diluted to 2ml  via the epidural 
catheter.  
GROUP F: Received 8ml of 0.125% bupivacaine and 1µ/kg 
of fentanyl diluted to 2ml via epidural catheter.   
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 The total volume of local anaesthetic solution 
administered to all the patients was 10 ml.  The solutions 
were prepared by an anaesthetist not involved in the study 
and the postoperative observer was blinded to the group 
allocation of the patient.  
 
 On the day of surgery in the operating room, basic 
monitors like ECG, pulse oximeter and non invasive blo od 
pressure were connected and a peripheral i.v. access was 
obtained using a 16 G i.v. canula.   Patients were 
premedicated with midazolam 0.02mg/kg i.v., inj.ranitidine 
50mg i.v., and inj. Glycopyrrolate 0.2mg i.v. and hydrated 
with 500ml of Ringer‟s Lactate solution . Patients were put 
in the right lateral position, the back was cleaned with 
povidone iodine solution and draped with sterile towels.  2 – 
3 ml of 2% lignocaine was infiltrated subcutaneously and 
16 G tuohy epidural needle was introduced into the  T6-7  or 
T7-8    interspinous space. In all patients the midline 
approach was used to enter into the interspinous space. 
Epidural space was identified using loss of resistance to air.  
Epidural catheter was inserted and directed in the cephalic 
direction, 3cm into the epidural space. The catheter 
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insertion site was tightly secured on the back with plasters  
and a bacterial filter was attached to the epidural catheter. 
If vascular puncture was encountered, the space above was 
chosen for the block. If dural puncture was encountered 
during the attempt, the space above the one which had dural 
puncture was used to give the block. After successful 
catheterisation the patients were turned supine and a  3 ml 
test dose of 1.5% lignocaine with 1in 2,00,000 adrenaline 
was given through the epidural catheter to rule out 
intrathecal or intravascular placement . The patients were 
preoxygenated for 3 – 5 min. Inj. Fentanyl 2µg/kg was used 
as analgesic. Patients were induced with inj. thiopentone 
5mg/kg. Inj.vecuronium 0.1mg/kg was given for 
neuromuscular blockade followed by intubation with 
appropriate sized single lumen or double lumen 
endotracheal tube, according to the case. Correct tube 
position was confirmed by auscultation. In all patients 
bladder was catheterised prior to surgery.  Anaesthesia was 
maintained with sevoflurane with oxygen 40% and nitrous 
oxide 60% and vecuronium. Intraoperatively analgesia was 
provided by fentanyl and repeated regularly as required.  
Blood loss was replaced and other complications were 
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managed appropriately. All the patients were given 
diclofenac 100mg suppository at the end of surgery to 
attenuate any anticipated visceral or shoulder tip pain in the 
post operative period. After the surgery was over, patient‟s 
blood pressure and heart rate were noted down. These 
values were taken as the baseline values for the subsequent 
hemodynamic measurements. The study drug was 
administered at the end of the surgery via the epidural 
catheter, after carefully aspirating the syringe for the 
presence of blood or csf. The drug was injected at a rate of 
1ml per second. Once the patients had spontaneous 
respiratory attempts they were reversed with 50 µ/kg 
neostigmine and 20 µ/kg of glycopyrolate.  Patients were 
extubated after adequate recovery of pharyngeal reflexes .  
Visual analogue scoring and vital parameters were recorded 
15 minutes after giving the study drug or after extubation, 
whichever was later. 
 
 Procedure was considered as a failure if,  there was 
unsatisfactory post operative analgesia with a VAS greater 
than 4 at the first assessment at 15 minutes after giving the 
block or after extubation, whichever  is later.  
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POST OPERATIVE MONITORING: 
 Patient‟s vital parameters – HR, SBP, DBP, MAP, RR, 
SpO2, level of sedation and pain assessment were done 
every 15 min in the first hour, every half an hour in the 
second hour and then hourly for 6 hours. Pain assessment 
was done using visual analogue score as marked by the 
patients and sedation was assessed by the five point 
sedation score. In all the patients supplementary oxygen 
was given via a facemask with flow of 3 – 4 litres per 
minute for 12hours. 
 
GRADING OF VISUAL ANALOGUE SCORE:  
0 – Does not hurt. 
2 – Hurts just a little bit.  
4 – Hurts a little more.  
6 – Hurts even more. 
8 – Hurts a lot. 
10 – Hurts as much as you can imagine.  
 
FIVE POINT SEDATION SCORE: 
Grade 1 - alert, awake, no sedation  
Grade 2 - arousable to verbal command  
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Grade 3 - arousable with gentle tactile stimulation   
Grade 4 - arousable with vigorous shaking  
Grade 5 - unarousable  
 
 At any point of time when the VAS was more than 3, 
rescue analgesia was given. The time interval between the 
administration of epidural drug and the first analgesic dose 
was calculated as the duration of analgesia. Rescue 
analgesia was given in the form of intravenous morphine up  
to a maximum of 0.2 mg /kg.  
 
 Any episode of sedation, nausea, vomiting, itching, 
motor blockade, hypotension, bradycardia and low 
respiratory rate were recorded at the same time as pain 
scores. 
 
SIDE EFFECTS: 
 Bradycardia was defined as a heart rate slower than 50 
beats per minute for the purpose of this study. It was 
treated with inj. Atropine 0.6mg i.v.  
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 Hypotension was defined as systolic blood pressure 
less than 90 mmhg or a fall in mean arterial pressure more 
than 20% from baseline and was treated with a rapid 
infusion of 250 ml of normal saline. This was followed by 
inj. Ephedrine 3mg i.v. in repeated boluses, if the systolic 
blood pressure did not increase above 90mmhg within 2 
minutes from the baseline value. 
 
 Respiratory depression was defined as respiratory rate 
below 8 per minute. It was managed with supplementary 
oxygen. Hypoxia was defined as a saturation of less than 90 
% and was managed with supplementary oxygen.  Vomiting 
was managed with inj. Ondansetron 4  mg i.v.  
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OBSERVATION AND RESULTS 
             
 We enrolled a total of 50 patients who underwent 
elective thoracotomy in the study and randomly divided 
them into two groups.  25 patients were allotted to group D 
and 25 were allotted to group F.  
 
Calculation of sample size:  
 The sample size was calculated using openepi 
software version 2.3. Sample size was calculated with a n 
alpha error of 5%, power of 95% and mean time required 
for first analgesic requirement in dexmedetomidine group 
of 366 minutes with a standard deviation of 24.42
(1)
. We 
assumed a decrease in value of 5% to be clinically 
significant. Using these values the sample size was 24 in 
each group. Hence we recruited 25 subjects in each group.  
 
Results have been expressed as mean with  standard 
deviation for duration of analgesia, quality of analgesia, 
heart rate and blood pressure variations. Level of sedation 
was expressed as median with range.  Side effects have 
been expressed as number and percentage. All statistical 
58 
 
analysis was done using SPSS for windows version 15.0. 
We used t – test for comparing quantitative variables and 
chi – square test for comparing qualitative variables. A p 
value of less than 0.05 was considered statistically 
significant. 
               
DEMOGRAPHIC DATA: 
Table No. 1: Demographic Profile (student’s t test) 
Demographic 
Characteristics 
Group D 
Mean + S.D. 
Group F 
Mean + S.D 
P value 
Age (years) 36.68±8.24 40.72±6.55 0.338 
Weight (kg) 61.72±7.76 63.60±7.43 0.386 
Height (cm) 165±4.66 166±4.26 0.530 
BMI (kg/m
2
) 22.33±1.89 22.95±1.68 0.229 
Sex Ratio (M:F)
* 64:36
* 
72:28
* 
0.544 
ASA (II:III)
* 60:40
* 
56:44* 0.774 
Duration of surgery  
(min) 
 
182±9.41 181±10.38 0.854 
Type of surgery* 
- Lobectomy 
- Mass excision 
- Bulla excision 
- Decortication 
 
15 
1 
1 
8 
 
 
15 
1 
0 
9 
 
 
 
0.787 
 
* (chi-square test) 
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Both the groups were comparable in their demographic 
characteristics like age, height, and weight and body mass 
index. The mean age of patients allotted in group D was 
36.68 yrs and was 40.72 yrs in patients allotted to group F. 
The age distribution in group D was from 25 to 55 yrs and 
in group F was from 28 to 57 yrs. The mean body mass 
index of the patients was 22.33 in group D and 22.95 in 
group F.  
 
 There were 16 male patients in group D and 18 male 
patients in group F. There were 9 female patients in group 
D and 7 female patients in group F. The sex ratio was 
similar in both the groups.  
  
 The distribution of patients according to ASA physical 
status were similar in both the groups: 15 patients in the 
dexmedetomidine group and 14 patients in fentanyl group 
belonged to ASA class II . 10 patients in the 
dexmedetomidine group and 11 patients in fentanyl group 
belonged to ASA class III.   
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The types of surgery performed were also equally 
distributed between the two groups. 15  patients in each of 
the two groups had undergone lobectomies, 8 patients in 
group D and 9 patients in group F had undergone 
decortications, 1 patient each in both the groups had 
undergone lung mass resection and 1 patient in group D had 
a bulla excision.  
 
 The mean duration of the surgery was 182 minutes in 
group D and 181 minutes in group F, being similar in both. 
All the patients who were enrolled in the study were 
extubated on table after surgery. Intercostal drainage tubes 
were inserted in all the patients at conclusion of surgery .  
No resection of ribs was done in any of the patients.  In two 
patients attempted epidural catheterisation was unsuccessful 
and they were excluded from the study. Three patients had 
excessive blood loss during surgery and major fluid shifts 
and they were excluded from the study. Accidental dural 
puncture during epidural catheterisation occurred in three 
patients but there was no incidence of post dural puncture 
headache in any of them. 
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DURATION OF ANALGESIA:  
With respect to the pain relief, patients in the D 
(dexmedetomidine) group had a smooth and prolonged post 
operative analgesia when compared to F (fentanyl) group.  
The mean duration of analgesia as determined by the time 
to first rescue analgesia was significantly longer in the 
dexmedetomidine group (329.92 ±  23.058min) when 
compared to the fentanyl  group (110 ± 9.345 min) with a p 
value of <0.001 which was statistically highly significant.   
 
Table No.2: Comparison of mean duration of analgesia 
(student’s t test) 
Group Mean Duration Of 
Analgesia 
(Minutes) 
Standard 
Deviation 
 P value 
D 329.92 23.058 
<0.001 
F 110 9.345 
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Bar Diagram No.1: Comparison of Duration of Analgesia 
 
 
QUALITY OF ANALGESIA: 
Table No. 3:  Comparison of Postoperative Visual 
Analogue Scores (student’s t test)  
0
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Group D                              Group F
Time  In 
Minutes 
Group D 
Mean +  S.D. 
Group F 
Mean +  S.D. 
P Value 
30 0.00 ± 0.00 1.12  ±  0.66 <0.001 
45 0.04 ± 0.20 1.20  ±  0.64 <0.001 
60 0.32 ± 0.47 2.00  ±  0.40 <0.001 
90 0.60 ± 0.50 2.40  ±  0.50 <0.001 
120 1.24 ± 0.59 3.76  ±  0.43 <0.001 
180 1.76 ± 0.52 - - 
240 2.32 ± 0.47 - - 
300 3.16 ± 0.55 - - 
360 3.92 ± 0.27 - - 
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The patients in the D group experienced less pain than 
the F group. Visual analogue scores were always below 3 in 
both the D and F group and were much lower in the D group 
when compared to the F group.  The mean visual analogue 
score during the period of analgesia was 1.25±0.25 in 
patients belonging to group D and 1.68±0.31 in patients 
belonging to group F which was highly significant (p value 
<0.001).  Visual analogue scores in the dexmedetomidine 
group were 0 in the first one and a half hours and were 
between 1-2 in the next two hours and 3 thereafter. In the 
fentanyl group the visual analogue score was  between 1 and 
3 in the 2 hour period. The differences in VAS between the 
two groups at all the time intervals  were statistically highly 
significant.  
 
LEVEL OF SEDATION:  
The sedation scores for both the groups are expressed 
as median and range. Median sedation scores were 
significantly higher in the dexmedetomidine group 
compared to the fentanyl group.  The patients were calm, 
easily arousable and comfortable in the dexmedetomidine  
group. The median sedation scores were between 2 and  3 in 
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the first two and a half hours & between 1 and 2 in the next 
three hours in the dexmedetomidine group. In the fentanyl 
group the median sedation scores were ranging from 1 to 2. 
 
Table No.4: Comparison of Sedation Scores (Chi-Square 
test) 
Time 
Min 
Group  D 
Median(Range) 
Group F 
Median(Range) 
P Value 
 
15  
 
3(2-3) 
 
2(1-2) 
 
<0.001 
 
30  
 
3(2-3) 
 
1(1-2) 
 
<0.001 
 
45  
 
3(2-3) 
 
1(1-2) 
 
<0.001 
 
60  
 
3(2-3) 
 
1(1-2) 
 
<0.001 
 
90  
 
2(2-3) 
 
1(1-2) 
 
<0.001 
 
120  
 
2(2-3) 
 
1(1-2) 
 
<0.001 
 
180  
 
2(1-3) 
 
- 
 
- 
 
240 
 
1(1-2) 
 
- 
 
- 
 
300  
 
1(1-2) 
 
- 
 
- 
 
360  
 
1(1-2) 
 
- 
 
- 
 
 No patients in either of the groups had sedation score 
of 4 or 5 at any point of time. The percentage wise 
distribution of sedation scores at various time intervals 
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between the two groups are summarised in the following 
table. 
 
Table No.5: Distribution of Sedation Scores between the 
Two Groups 
Time in 
minutes 
Sedation score 1  Sedation score 2  Sedation score 3 
Group D 
No. of 
pts (%) 
Group F 
No. of pts    
(%) 
Group D 
No. of pts 
(%) 
Group F 
No. of 
pts (%) 
Group D 
No. of 
pts (%) 
Group F 
No. of 
pts (%) 
15 0 (0%) 2 (8%) 1 (4%) 23 (92%) 24 (96%) 0 (0%) 
30 0 (0%) 20 (80%) 4 (6%) 5 (20%) 21 (89%) 0 (0%) 
45 0 (0%) 21 (84%) 4 (16%) 4 (16%) 21 (84%) 0 (0%) 
60 0 (0%) 25(100%) 10 (40%) 0 (0%) 15 (60%) 0 (0%) 
90 0 (0%) 25 100%) 12 (48%) 0 (0%) 11 (44%) 0 (0%) 
120 0 (0%) 25(100%) 25(100%) 0 (0%) 0 (0%) 0 (0%) 
180 2 (8%) - 22 (88%) - 1 (4%) - 
240 14 (56%) - 11 (44%) - 0 (0%) - 
300 23 (92%) - 2 (8%) - 0 (0%) - 
360 24 (96%) - 2 (8%) - 0 (0%) - 
 
 
 
 
66 
 
HEMODYNAMIC CHANGES: 
Systolic Blood Pressure: 
There was a fall in systolic blood pressure from the 
baseline after injection of the drug in both the groups . The 
decrease in blood pressure was mild  and gradual in both the 
groups. There was no statistically significant between the 
two groups in the first 45 minutes after injection on drug.  
In the 60 to 120 minute period the systolic blood pressure 
values of group D was lesser than group F and was 
statistically significant. After two hours, there was a steady 
rise in systolic blood pressure in group D almost 
approaching baseline values and was stable.  
Line diagram No.1: Comparison of systolic blood 
pressures  
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Table No.6: Comparison of systolic blood pressure  
(student’s t test)  
Time  
minutes 
Group D 
Mean +  S.D. 
Group F 
Mean +  S.D. 
P value 
0 117.08±14.12 122.36±9.725 0.130 
5  108.88±16.47 114.76±9.748 0.131 
15  102.56±9.78 106.04±8.228 0.180 
30 98.96±7.87 101.76±8.171 0.223 
45  103.56±7.92 113.20±12.23 0.002 
60  101.96±9.81 114.6413.073 0.000 
90  99.44±10.76 109.7210.888 0.002 
120  104.36±11.20 118.00±15.17 0.001 
180  
102.40±9.73 
 
- - 
240  
103.20±19.03 
 
- - 
300  
111.60±10.59 
 
- - 
360  
117.92±12.29 
 
- - 
 
Diastolic Blood Pressure:  
 Similar to the systolic blood pressures, there was a 
mild and gradual fall in diastolic blood pressures after 
injection of drug in both the groups. There were no 
statistically significant differences  in diastolic blood 
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pressures between the two groups in the first 60 minutes of 
injection of drug. At 90 minutes and at 120 minutes the 
diastolic blood pressure values of group D was lesser than 
group F and was statistically significant. After two hours, 
there was a steady rise in systolic  blood pressure in group D 
almost approaching baseline values and was stable.  
 
Line Diagram No.2: Comparison of Diastolic Blood 
Pressures  
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Table No.7: Comparison of diastolic blood pressure   
Time 
minutes 
Group D 
Mean +  S.D. 
Group D 
Mean +  S.D. 
P value 
 
0 
 
77.32±9.72 81.529.097 0.121 
 
5 
 
74.32±11.88 73.12±7.93 0.676 
 
15 
 
68.96±9.58 70.48±6.79 0.521 
 
30 
 
62.60±9.44 63.88±6.68 0.583 
 
45 
 
66.96±6.61 70.52±8.12 0.096 
 
60 
 
65.92±9.88 70.56±8.37 0.080 
 
90 
 
62.72±8.58 71.84±7.65 0.001 
 
120 
 
66.80±10.73 75.64±11.547 0.007 
180 
 
66.12±10.89 
 
- - 
240 
 
68.80±12.28 
 
- - 
300 
 
70.44±10.39 
 
- - 
360 
 
75.76±10.60 
. 
- - 
 
Mean Arterial Pressure:  
 There was a 10 to 15% decrease in the mean arterial 
pressure in both the groups after injection of the drug; 
corresponding to the systolic and diastolic blood pressure 
values. The differences between the mean arterial pressures 
were similar during the first 45 minutes of injection of the 
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drug. After 45 minutes, up to two hours, the mean arterial 
pressures were significantly lesser in the dexmedetomidine 
group than in the fentanyl group. Later there was a steady 
increase in mean arterial pressure approaching towards the 
baseline values in group D.  The absolute values are 
depicted in table no. 8. 
 
Table No.8: Comparison of Mean Arterial Pressure  
Time in 
minutes 
Group D 
mean ± S.D 
Group F 
Mean ± S.D. 
P value 
0  89.00±12.148 95.00±9.083 0.054 
5  85.12±11.76 85.76±8.861 0.829 
15  79.84±8.11 83.72±6.937 0.075 
30  72.48±6.92 75.48±7.136 0.138 
45  79.32±6.34 83.80±9.055 0.048 
60  77.76±8.30 84.32±9.890 0.014 
90  74.96±9.11 84.64±8.631 0.001 
120 78.96±8.87 89.44±12.292 0.001 
180    78.84±7.79 - - 
240  80.84±10.94 - - 
300  84.44±9.31 - - 
360  88.96±10.46 - 
- 
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Line Diagram No.3: Comparison of Mean Arterial 
Pressures 
 
 
Table No.9:  Comparison of Decrease in Mean Arterial 
Pressure 
MAP 
Group D 
Mean ± S.D. 
Group F 
Mean ± S.D. 
P value 
Baseline(mmhg) 89.00 ± 12.14 95.00 ± 9.08 0.054 
Maximal 
Decrease(mmhg) 
 
17.72 ± 9.05 20.92 ± 10.17 
0.246 Percentage of 
Maximal Decrease 
 
19.91%
 *  
22.02%* 
Time (min) 33.00 ± 6.124 31.20 ± 7.39 
*percentage 
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 The magnitude of maximal decrease in the MAP was 
17mmhg in the D group and 20.92mmhg in F group as 
shown in table no.9. The percentage of decrease in MAP 
was 19.91% in group D and 22% in group F. This decrease 
occurred at around 30 minutes of injection of drug in both 
the groups. The results were not statistically significant.  
 
HEART RATE: 
 Heart rate reduction was observed in both the groups 
when compared to baseline values. But the amount of 
decrease was more in group D, being significant 
statistically in the second hour. After two hours there was a 
steady increase in heart rate, almost trying to approach 
baseline values.  
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Table No.10: Comparison of Heart Rate  
Time in 
minutes 
Group D 
Mean ± S.D. 
Group F 
Mean ± S.D. 
P value 
0 80.32±6.26 83.48±9.06 0.158 
5 77.48±5.83 77.52±9.97 0.986 
15 70.36±6.42 73.48±7.55 0.122 
30 65.19±5.63 71.68±7.38 <0.001 
45 67.65±5.82 73.56±8.85 0.006 
60 72.19±5.19 78.28±10.45 0.007 
90 72.96±5.90 75.04±9.14 0.343 
120 68.80±6.40 81.28±7.35 1.008 
180 68.88±5.61 - - 
240 69.34±5.42 - - 
300 70.48±5.06 - - 
360 73.32±5.27 - - 
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Line Diagram No.4: Comparison of Heart Rate 
 
 
 The magnitude of maximal decrease in heart rate was 
16 beats per min in group D as compared to 12 beats per 
min in group F. The percentage of maximal decrease  in the 
heart rate after injection of the drug was 19% in group D 
and 14% in group F. The peak time of decrease in heart rate 
was observed after 30 minutes of drug injection in both the 
groups. The percentage of maximum difference in heart rate 
was highly significant between the two groups with a p – 
value of 0.001. 
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Table No.11: Comparison of decrease in heart rate 
(student’s t test) 
 
Heart Rate 
 
Group D 
Mean ± S.D. 
Group F 
Mean ± S.D. 
 
P value 
Baseline HR 
 
80.32±6.26 83.48±9.06 0.158 
Magnitude of 
Maximal Decrease 
 
 
15.84±2.83 
 
11.80±5.18 
 
0.001 
Percentage of 
Maximal Decrease 
 
 
19.39%
* 
 
14.13%
* 
 
Time 
 
 
28.20±6.5 
 
29.20±9.4 
* percentage 
 
SIDE EFFECTS: 
 There were no statistically significant differences 
between the groups in the incidence of nausea, vomiting, 
dry mouth and pruritus. The number and percentage of 
patients who complained of nausea, vomiting and dry mou th 
are summarized in the table.  
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Table No.12: Incidence of side effects  (Chi-Square test) 
Side Effect 
Group D 
Number (%) 
Group F 
Number (%) 
P value 
Bradycardia 1 (4%) 0 (0%)  0.312 
Hypotension 1 (4%) 1 (4%) 1.000 
Nausea 2 (8%) 3 (12%) 0.637 
Vomiting 0 (0%) 2 (8%) 0.149 
Dry Mouth 3 (12%) 0 (0%) 0.074 
Pruritus 0 (0%) 2 (8%) 0.149 
Respiratory 
Depression 
0 (0%) 0 (0%) 1.000 
 
 There was one incidence of significant bradycardia in 
a patient in the D group. It was appropriately treated with 
atropine.  There was no episode of bradycardia in the 
fentanyl group.  Two patients – one in group D and one in 
group F had significant hypotension with no associated 
excessive blood loss. It subsided with intravenous fluids 
and ephedrine administration.  There was no incidence of 
respiratory depression (RR < 10 or sPO2   <90%) in either of 
the groups.  There was no incidence of postoperative 
neurological deficit in any of the patients.  
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DISCUSSION 
 
 It is a well known fact that thoracic epidural analgesia 
provides effective pain relief after thoracotomy. The 
commonly used drugs for pain relief following thoracic 
epidural are usually local anaesthetics.  When used in high 
concentration local anaesthetics are associated with 
hypotension. If given in low concentration the analgesia 
becomes often inadequate.  Hence opioids were given as 
additives to local anaesthetic in order to decrease the need 
for administering high concentration of local anaesthetic . 
Epidural opioids did reduce the incidence of postoperative 
complications like atelectasis and pneumonia and we re tried 
as a sole analgesic postoperatively but were not popular due 
to the higher concentration required and the due to the 
incidence of respiratory depression.  
 
 It is a well established fact that synergistic effect 
occurs when local anaesthetics and opioids are given 
together neuraxially.  This can be used to reduce the 
concentration of local anaesthetics and opioids used by 
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epidural route for post operative analgesia and reduce the 
incidence of side effects when given separately.  
 
 Fentanyl is one of the commonly used neuraxial 
opioid along with local anaesthetics to provide better 
postoperative analgesia.  But increasing the concentration 
of fentanyl to provide better postoperative analgesia is 
associated with dose dependent side effects like nausea, 
pruritus, sedation and respiratory depression.  
 
In order to avoid the undesirable side effects of 
opioids like respiratory depression at high concentration 
especially after thoracotomy it may be desirable to use 
other neuraxial adjuvant like α2 adrenergic receptor 
agonists - clonidine and dexmedetomidine.  
Dexmedetomidine is more selective at α2 receptor when 
compared to clonidine. Hence we used dexmedetomidine 
in this study. 
 
 α2 adrenergic  agonists (dexmedetomidine )  also 
possesses analgesic properties like opioids but the 
advantage is that it lacks the respiratory depression like 
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opioids.  Dexmedetomidine helps in maintaining sedation 
without cardiovascular instability or respiratory  depression.  
Dexmedetomidine also acts synergistically with local 
anaesthetics by prolonging the duration of sensory and 
motor block and by providing prolonged duration of 
analgesia when compared to local anaesthetics alone.  
 
In view of the advantages of dexmedetomidine we 
performed the study to compare the analgesic and adverse 
effect profile between epidurally administered fentanyl and 
dexmedetomidine in patients undergoing thoracotomy.  
 
We found that dexmedetomidine is better when 
compared to fentanyl as it is superior in providing better 
pain score and more comfort and intense analgesia in the 
postoperative period. The duration of analgesia is more 
when dexmedetomidine is added to bupivacaine. The time 
to first rescue analgesia was approximately 320 minutes 
after the first dose whereas in case of fentanyl it is around 2  
hours which is correlates with the study conducted by S 
Bajwa et al and Schnaider et al . No abnormal motor or 
sensory deficits were observed in any patients in both the 
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groups. Dexmedetomidine produces this effect of prolonged 
duration of analgesia by its  action on the superficial dorsal 
horn of the spinal cord.  It acts by inhibiting the release of 
neurotransmitters from primary afferent nerve terminals 
like substance P and glutamate and by causing 
hyperpolarisation of interspinal neurons.  
 
Sedation score was higher in the dexmedetomidine 
group when compared to fentanyl group but none of the 
patients in either group had profound respiratory depression 
or deep sedation requiring intervention as mentioned in 
other studies. This could be due to the low dose o f 
dexmedetomidine used in our study.  The patients in the 
dexmedetomidine group were calm and awake and could 
communicate without any agita tion. The sedation in the 
dexmedetomidine group is  because of its action on the locus 
ceruleus causing decreased firing of the neurons along with 
inhibition of nor epinephrine release and activity in the 
descending medullospinal noradrenergic pathway, 
secondary to activation of central α2 adrenergic receptor. 
The reduced sedation score in the fentanyl group could be 
because of the lower dose of fentanyl used in our study.  
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Hemodynamic fluctuations were noticed in both the 
groups.  The fall in the heart rate and blood pressure were 
noticed in both the groups but the fall was more in the 
dexmedetomidine group when compared to the fentanyl 
group. The maximum fall in heart rate and blood pressure 
was around 30 to 45 minutes in both the groups.  Mean 
heart rate and blood pressure were stable in both the groups 
after this fall and none of them required any intervention 
after this. The patients were hemodynamically stable in 
both the groups. The maximum reduction of mean arterial 
pressure was around 19% in the dexmedetomidine group in 
our study, whereas Schnaeder et al and El Hennaway et al 
observed a 25% reduction in mean arterial pressure. This 
could be because they used 2 µ/kg of dexmedetomidine 
whereas in our study we used 1µ/kg. The fall in blood 
pressure and pulse rate caused by dexmedetomidine can be 
attributed to central α2A adrenergic receptor causing  
reduced release of nor adrenaline from the sympathetic 
nervous system.  
 
There were complaints of pruritus by 2 patients in the  
fentanyl group while none of the patients in the 
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dexmedetomidine group complained of any pruritus. The 
pruritus occurred in both the patients within an hour after 
fentanyl administration and lasted for 30 minutes and was 
localized to the face.  No intervention was required in both 
the patients as the symptoms resolved by its own. 
 
Two patients in group D and 3 patients in Group F 
group complained of nausea. But none of the patients in 
either group required any intervention and was self 
limiting.  
 
 We did not notice any incidence of respiratory 
depression in both the groups.  The reduced incidence of 
respiratory depression in the fentanyl group could be 
because of the low dose of the epidural fentanyl bolus given 
in these patients.  
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SUMMARY 
 
 This double blinded  prospective randomized 
controlled study was done to evaluate the duration of 
analgesia as well as  sedation and adverse effects of 
dexmedetomidine( 1µg/kg) and fentanyl (1 µg/kg) given via 
epidural route with 0.125%  bupivacaine in patients  p ost 
operatively who underwent thoracotomy surgeries under 
general anaesthesia.  
 
The following observations were made:  
 The addition of dexmedetomidine to 0.125% bupivacaine 
significantly prolonged the duration of post operative 
analgesia compared to fentanyl. 
 The quality of analgesia was significantly better when 
dexmedetomidine was added to bupivacaine rather than 
fentanyl. 
 The addition of dexmedetomidine epidurally produced 
sedation that was arousable for many hours.  
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 The incidence of side effects such as hypotension, 
bradycardia, nausea, vomiting and pruritus were not 
statistically significant between the groups.  
 No episode of respiratory depression was noted in both 
the study groups which are more common with opioids.  
  Hemodynamic stability was well maintained in patients 
belonging to both the groups. 
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CONCLUSION 
 
In conclusion, dexmedetomidine appears to have a 
beneficial effect as an adjuvant to local anaesthetic by 
improving the quality and increasing the duration of 
analgesia without the side effects associated with opioids 
like respiratory depression. It has minimal side effects and 
good hemodynamic stability. However its routine use in 
epidural route requires caution with regard to its effects due 
to central sympatholytic property and fur ther studies are 
necessary to quantify the required dosage. 
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MASTER CHART 
      
GROUP D –  DEXMEDETOMIDINE  
S.NO NAME AGE SEX WEIGHT HEIGHT BMI ASA - PS PROCEDURE FAILURE 
DURATION OF 
SURGERY (in 
minutes) 
DURATION OF  
ANALGESIA 
(in minutes) 
1 Kathirvel 40 M 60 165 22.03 II lobectomy no 182 330 
2 Muthusamy 45 M 65 170 22.49 III decortication no 170 350 
3 Kuppan 50 M 66 169 23.10 II lobectomy no 190 332 
4 Seetha 35 F 50 155 20.81 II decortication no 175 320 
5 Ananthi 38 F 55 160 21.48 III bulla excision no 183 321 
6 Chinnaraj 38 M 72 171 24.62 III mass exccision no 182 375 
7 Savithri 36 F 56 163 21.07 II decortication no 192 350 
8 Vasantha 40 F 51 165 18.73 II lobectomy no 200 370 
9 Murugesan 45 M 71 172 23.99 II lobectomy no 168 340 
10 Pandu 40 M 69 169 24.15 II lobectomy no 172 300 
11 Vinoth 22 M 66 169 23.10 II lobectomy no 180 340 
12 Murugesan 40 M 52 167 18.64 II lobectomy no 182 345 
13 Iyyapan 34 M 67 168 23.73 III lobectomy no 192 345 
14 Asairaj 35 F 54 159 21.35 II lobectomy no 184 355 
15 Malar 32 F 55 160 21.48 III decortication no 175 320 
16 Vinoth 36 M 65 162 24.76 III decortication no 173 315 
17 Uma rani 37 F 57 163 21.45 II lobectomy no 191 340 
18 Manickam 40 M 66 170 22.83 III decortication no 178 350 
19 Gopal 31 M 70 172 23.38 III decortication no 176 295 
20 Senthil 55 M 66 168 23.38 II lobectomy no 186 290 
21 Ramya 28 F 52 163 19.57 II lobectomy no 200 310 
22 Nandagopal 40 M 67 169 23.45 II lobectomy no 168 290 
23 Sathyamurthy 50 M 66 167 23.66 II decortication no 192 315 
24 Kuppu 55 F 50 160 19.53 III lobectomy no 170 320 
25 Raja 25 M 75 171 25.64 III lobectomy no 175 330 
 GROUP F - FENTANYL 
S.NO NAME AGE SEX WEIGHT HEIGHT BMI ASA - PS PROCEDURE FAILURE 
DURATION OF 
SURGERY (in 
minutes) 
DURATION OF  
ANALGESIA 
(in minutes) 
1 Mani 38 M 65 169 22.70 II lobectomy no 180 110 
2 Marimuthu 46 M 60 166 23.43 II decortication no 170 99 
3 Kesavan 48 M 59 163 22.21 III lobectomy no 190 120 
4 Amsavalli 56 F 52 160 20.31 III lobectomy no 175 110 
5 Purushothaman 43 M 73 170 25.25 II lobectomy no 183 125 
6 Saravanan 39 M 74 172 25.01 II lobectomy no 182 95 
7 Arumugam 47 M 70 172 23.66 II decortication no 192 100 
8 Shanmugam 36 M 69 170 23.87 III decortication no 200 105 
9 Vadivel 49 M 65 165 23.87 III lobectomy no 168 110 
10 George 57 M 70 168 24.80 III mass excision no 172 125 
11 Dhivya 30 F 59 163 22.20 II decortication no 193 95 
12 Kamal 28 M 63 166 22.80 II lobectomy no 182 110 
13 Irfaan 50 M 66 165 24.24 III lobectomy no 192 110 
14 Chitra 51 F 58 164 21.56 II lobectomy no 184 105 
15 Manickam 52 M 60 166 21.77 III lobectomy no 165 125 
16 Vinoth 48 F 52 159 20.56 II decortication no 173 100 
17 Arunan 43 M 64 166 23.22 II decortication no 191 105 
18 Jeeva 53 F 57 164 23.19 II decortication no 178 105 
19 Lakshmi 40 F 51 165 18.73 II lobectomy no 176 124 
20 Thilaga 39 F 51 158 20.42 III decortication no 184 115 
21 Rajesh 34 M 65 170 22.49 III lobectomy no 200 100 
22 Sriinivasan 37 M 72 173 24.05 III lobectomy no 168 120 
23 Ponnusamy 36 M 73 174 24.11 II lobectomy no 195 110 
24 Rajasekar 41 M 69 169 24.15 III lobectomy no 170 115 
25 Amudha 40 M 73 170 25.25 II decortication no 175 112 
 
 
 
GROUP D – PULSE RATE 
S.NO NAME AGE SEX 0 min 5 min 15 min 30 min 45 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min 
1 Kathirvel 40 M 66 60 58 49 65 65 66 63 60 60 66 78 
2 Muthusamy 45 M 74 72 65 64 66 67 68 65 68 69 78 85 
3 Kuppan 50 M 70 71 64 58 62 74 76 74 76 72 73 71 
4 Seetha 35 F 86 82 72 67 67 67 67 67 68 68 69 72 
5 Ananthi 38 F 76 75 64 60 62 70 72 62 63 62 70 70 
6 Chinnaraj 38 M 80 82 74 64 64 66 64 59 59 64 62 63 
7 Savithri 36 F 82 76 72 65 66 76 83 82 83 82 83 82 
8 Vasantha 40 F 74 70 68 61 62 77 76 64 65 64 64 70 
9 Murugesan 45 M 80 79 68 67 73 68 68 70 70 66 76 80 
10 Pandu 40 M 82 80 72 67 67 72 74 67 68 69 70 77 
11 Vinoth 22 M 78 76 72 64 68 73 70 70 70 71 70 70 
12 Murugesan 40 M 76 75 65 61 61 65 67 61 62 84 61 71 
13 Iyyapan 34 M 82 85 75 66 64 66 68 70 71 69 69 80 
14 Asairaj 35 F 82 78 69 66 67 73 69 70 70 67 69 70 
15 Malar 32 F 72 70 62 55 55 64 67 64 67 68 70 72 
16 Vinoth 36 M 82 82 76 64 64 74 73 64 65 65 68 79 
17 Uma rani 37 F 80 78 72 64 68 68 68 70 67 68 68 70 
18 Manickam 40 M 74 76 58 69 65 72 76 60 63 65 66 66 
19 Gopal 31 M 91 80 70 70 78 80 88 78 70 70 70 78 
20 Senthil 55 M 85 84 70 67 70 76 78 66 68 69 70 72 
21 Ramya 28 F 86 75 76 76 77 83 80 80 78 76 79 76 
22 Nandagopal 40 M 86 80 79 70 78 77 74 71 71 71 72 70 
23 Sathyamurthy 50 M 85 84 76 69 71 70 78 80 75 71 71 70 
24 Kuppu 55 F 84 82 78 70 72 79 78 71 70 70 73 71 
25 Raja 25 M 90 85 84 72 77 72 74 73 75 74 75 70 
 
 
 
 
GROUP F – PULSE RATE 
S.NO NAME AGE SEX 0 min 5 min 15 min 30 min 45 min 60 min 90 min 120 min 
1 Mani 38 M 90 80 76 70 70 83 84 88 
2 Marimuthu 46 M 95 90 80 84 85 100 92 90 
3 Kesavan 48 M 89 88 84 78 80 86 83 87 
4 Amsavalli 56 F 94 90 82 80 85 95 88 87 
5 Purushothaman 43 M 84 86 71 70 70 70 70 78 
6 Saravanan 39 M 90 93 84 80 81 94 84 86 
7 Arumugam 47 M 85 89 78 72 77 76 72 75 
8 Shanmugam 36 M 80 80 78 75 85 80 84 85 
9 Vadivel 49 M 96 80 82 81 80 84 80 85 
10 George 57 M 95 70 75 71 70 74 71 86 
11 Dhivya 30 F 78 69 71 70 78 71 71 80 
12 Kamal 28 M 72 62 62 61 60 68 62 79 
13 Irfaan 50 M 84 75 71 68 70 71 71 88 
14 Chitra 51 F 90 84 75 81 76 85 80 85 
15 Manickam 52 M 89 88 80 80 90 81 88 90 
16 Vinoth 48 F 65 63 61 60 60 58 60 60 
17 Arunan 43 M 62 62 58 57 59 59 60 70 
18 Jeeva 53 F 90 90 86 80 86 85 82 84 
19 Lakshmi 40 F 78 70 68 63 64 70 72 83 
20 Thilaga 39 F 83 70 70 69 66 81 74 83 
21 Rajesh 34 M 78 69 71 70 70 85 78 80 
22 Sriinivasan 37 M 89 76 70 71 72 83 70 76 
23 Ponnusamy 36 M 80 78 71 70 71 80 70 88 
24 Rajasekar 41 M 76 68 66 65 66 68 64 70 
25 Amudha 40 M 75 68 67 66 68 70 66 74 
 
 
 
 
 
 
GROUP D – SYSTOLIC BLOOD PRESSURE  
S.NO NAME AGE SEX 0 min 5 min 15 min 30 min 45 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min 
1 Kathirvel 40 M 124 104 89 90 104 98 115 100 92 106 110 130 
2 Muthusamy 45 M 132 100 104 100 105 102 109 104 100 100 108 128 
3 Kuppan 50 M 100 90 92 86 112 95 116 90 100 108 108 93 
4 Seetha 35 F 106 95 94 91 84 93 96 94 99 99 94 107 
5 Ananthi 38 F 107 109 108 119 91 121 95 125 107 120 121 123 
6 Chinnaraj 38 M 101 102 104 101 110 101 96 99 99 89 105 103 
7 Savithri 36 F 95 94 95 91 113 90 106 98 99 101 103 98 
8 Vasantha 40 F 95 88 90 92 115 90 111 90 94 97 98 110 
9 Murugesan 45 M 120 110 100 100 94 100 110 104 104 104 108 138 
10 Pandu 40 M 106 100 101 99 114 98 109 102 106 109 109 110 
11 Vinoth 22 M 100 90 92 86 117 120 113 123 101 111 108 126 
12 Murugesan 40 M 107 109 100 96 106 116 84 127 126 24 126 120 
13 Iyyapan 34 M 134 119 116 106 108 105 111 106 107 108 127 126 
14 Asairaj 35 F 126 95 94 95 94 91 96 100 89 86 90 101 
15 Malar 32 F 127 106 106 93 101 98 85 100 93 100 111 124 
16 Vinoth 36 M 100 95 94 95 101 91 90 100 102 118 106 107 
17 Uma rani 37 F 120 106 100 106 105 105 86 102 102 110 128 118 
18 Manickam 40 M 122 111 113 106 103 109 100 89 89 99 101 103 
19 Gopal 31 M 123 118 98 109 97 115 85 116 107 118 125 131 
20 Senthil 55 M 141 149 117 108 103 107 99 111 129 126 129 123 
21 Ramya 28 F 137 134 118 107 98 118 92 125 111 121 115 137 
22 Nandagopal 40 M 116 100 96 96 104 92 112 92 90 110 118 124 
23 Sathyamurthy 50 M 130 124 125 100 98 92 87 98 102 108 120 122 
24 Kuppu 55 F 129 137 109 101 106 101 91 107 106 104 111 123 
25 Raja 25 M 129 137 109 101 106 101 92 107 106 104 111 123 
 
 
 
 
GROUP F – SYSTOLIC BLOOD PRESSURE 
S.NO NAME AGE SEX 0 min 5 min 15 min 30 min 45 min 60 min 90 min 120 min 
1 Mani 38 M 112 129 119 104 128 117 129 124 
2 Marimuthu 46 M 121 101 104 102 105 107 127 141 
3 Kesavan 48 M 126 122 110 112 116 117 107 133 
4 Amsavalli 56 F 125 118 110 90 108 122 106 123 
5 Purushothaman 43 M 102 117 98 91 109 112 112 135 
6 Saravanan 39 M 130 106 116 110 122 128 97 117 
7 Arumugam 47 M 125 125 110 113 130 136 125 138 
8 Shanmugam 36 M 133 119 117 115 125 124 107 126 
9 Vadivel 49 M 136 124 122 94 122 125 103 130 
10 George 57 M 127 120 118 114 119 117 96 130 
11 Dhivya 30 F 121 125 110 117 131 134 115 128 
12 Kamal 28 M 126 101 104 96 102 100 119 105 
13 Irfaan 50 M 128 103 107 95 98 108 100 98 
14 Chitra 51 F 108 124 101 94 124 130 123 120 
15 Manickam 52 M 123 108 97 95 104 110 120 120 
16 Vinoth 48 F 129 122 103 101 135 138 108 125 
17 Arunan 43 M 125 124 106 105 125 126 118 128 
18 Jeeva 53 F 117 108 108 103 100 100 115 90 
19 Lakshmi 40 F 126 121 96 97 115 104 98 98 
20 Thilaga 39 F 105 120 95 103 109 105 105 112 
21 Rajesh 34 M 103 95 98 90 92 98 120 95 
22 Sriinivasan 37 M 118 104 101 96 104 94 97 95 
23 Ponnusamy 36 M 124 120 103 98 109 114 91 116 
24 Rajasekar 41 M 134 110 108 106 100 103 107 127 
25 Amudha 40 M 135 103 90 103 98 97 98 96 
 
 
 
 
 
 
GROUP D – DIASTOLIC BLOOD PRESSURE  
S.NO NAME AGE SEX 0 min 5 min 15 min 30 min 45 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min 
1 Kathirvel 40 M 78 70 70 60 62 62 75 66 64 70 69 80 
2 Muthusamy 45 M 84 70 68 66 63 67 70 64 63 62 70 76 
3 Kuppan 50 M 72 66 66 51 75 71 73 66 74 81 77 71 
4 Seetha 35 F 65 75 74 64 50 71 61 71 72 71 71 64 
5 Ananthi 38 F 81 81 81 83 64 85 62 77 64 83 80 82 
6 Chinnaraj 38 M 63 63 54 60 68 57 55 57 50 42 65 58 
7 Savithri 36 F 75 74 73 64 68 60 71 59 59 63 64 64 
8 Vasantha 40 F 63 56 48 46 72 60 70 63 56 56 50 62 
9 Murugesan 45 M 82 70 54 60 58 64 70 63 64 66 70 84 
10 Pandu 40 M 60 60 57 54 71 52 70 54 52 55 56 54 
11 Vinoth 22 M 70 70 74 55 73 75 71 92 72 76 77 91 
12 Murugesan 40 M 81 81 80 63 79 82 52 88 85 85 84 83 
13 Iyyapan 34 M 89 84 82 69 79 78 70 80 81 81 88 85 
14 Asairaj 35 F 91 75 74 60 73 64 58 74 66 51 66 72 
15 Malar 32 F 88 79 80 71 64 81 49 74 71 74 76 86 
16 Vinoth 36 M 70 75 74 73 62 64 53 62 64 81 79 81 
17 Uma rani 37 F 82 56 60 62 72 62 50 62 62 70 80 70 
18 Manickam 40 M 71 66 72 78 61 65 63 40 42 50 47 60 
19 Gopal 31 M 82 67 69 68 66 74 51 70 64 73 60 89 
20 Senthil 55 M 94 95 65 72 70 65 69 74 80 92 79 83 
21 Ramya 28 F 89 91 67 64 68 73 64 60 72 80 79 89 
22 Nandagopal 40 M 63 60 54 58 66 60 70 62 48 62 62 82 
23 Sathyamurthy 50 M 82 82 78 70 60 60 48 62 72 70 80 82 
24 Kuppu 55 F 78 96 75 47 65 48 59 65 78 63 66 73 
25 Raja 25 M 80 96 75 47 65 48 64 65 78 63 66 73 
 
 
 
 
GROUP F – DIASTOLIC BLOOD PRESSURE 
S.NO NAME AGE SEX 0 min 5 min 15 min 30 min 45 min 60 min 90 min 120 min 
1 Mani 38 M 70 80 80 62 75 65 85 85 
2 Marimuthu 46 M 82 60 75 61 63 72 82 94 
3 Kesavan 48 M 85 71 75 75 73 74 68 91 
4 Amsavalli 56 F 85 78 73 50 68 72 70 78 
5 Purushothaman 43 M 60 71 60 64 65 70 70 93 
6 Saravanan 39 M 88 78 68 68 84 80 67 71 
7 Arumugam 47 M 83 82 80 72 80 84 82 80 
8 Shanmugam 36 M 87 78 74 58 70 68 65 72 
9 Vadivel 49 M 90 76 78 71 82 80 63 82 
10 George 57 M 85 82 83 73 72 70 62 82 
11 Dhivya 30 F 80 82 70 63 86 84 73 92 
12 Kamal 28 M 84 60 75 69 61 58 79 58 
13 Irfaan 50 M 86 64 78 60 64 62 82 63 
14 Chitra 51 F 67 74 60 64 76 84 82 82 
15 Manickam 52 M 84 60 63 50 62 60 80 72 
16 Vinoth 48 F 88 80 65 72 84 85 71 82 
17 Arunan 43 M 86 72 67 61 71 74 75 73 
18 Jeeva 53 F 75 64 67 54 58 66 70 50 
19 Lakshmi 40 F 86 83 65 62 75 70 67 65 
20 Thilaga 39 F 70 80 66 68 70 63 63 80 
21 Rajesh 34 M 65 64 66 62 64 68 80 63 
22 Sriinivasan 37 M 78 63 78 58 60 60 67 61 
23 Ponnusamy 36 M 84 81 64 65 70 71 58 75 
24 Rajasekar 41 M 90 75 70 68 63 61 68 80 
25 Amudha 40 M 100 70 62 67 67 63 67 67 
 
 
 
 
 
 
GROUP D – MEAN ARTERIAL PRESSURE 
S.NO NAME AGE SEX 0 min 5 min 15 min 30 min 45 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min 
1 Kathirvel 40 M 93 86 80 70 76 74 88 77 80 82 102 96 
2 Muthusamy 45 M 100 80 82 77 77 79 83 77 72 74 83 93 
3 Kuppan 50 M 63 74 73 63 87 78 87 74 83 90 87 78 
4 Seetha 35 F 73 82 81 73 61 78 73 79 81 80 79 75 
5 Ananthi 38 F 90 90 90 95 73 97 73 87 75 95 90 91 
6 Chinnaraj 38 M 72 72 70 69 82 67 69 68 64 55 76 70 
7 Savithri 36 F 82 81 80 69 83 76 83 69 70 72 74 74 
8 Vasantha 40 F 74 66 62 61 86 70 84 72 68 70 66 78 
9 Murugesan 45 M 95 83 70 69 73 76 83 77 77 79 83 102 
10 Pandu 40 M 76 73 72 69 85 70 83 70 70 73 74 73 
11 Vinoth 22 M 80 81 78 65 88 83 85 104 82 88 87 103 
12 Murugesan 40 M 90 90 89 74 88 93 63 101 99 98 98 95 
13 Iyyapan 34 M 104 96 93 82 88 87 84 89 90 90 101 99 
14 Asairaj 35 F 103 82 81 71 80 73 71 83 74 63 74 82 
15 Malar 32 F 101 88 89 76 78 90 61 83 78 83 88 99 
16 Vinoth 36 M 80 82 81 71 70 73 65 74 78 93 88 90 
17 Uma rani 37 F 95 73 73 77 83 76 62 75 75 83 96 86 
18 Manickam 40 M 81 79 84 74 78 81 75 79 79 74 76 78 
19 Gopal 31 M 91 81 76 75 78 85 62 81 75 83 77 101 
20 Senthil 55 M 110 117 77 74 81 82 79 84 91 101 92 94 
21 Ramya 28 F 104 103 81 75 78 83 73 77 81 90 88 104 
22 Nandagopal 40 M 81 73 68 71 79 71 84 72 75 78 81 96 
23 Sathyamurthy 50 M 98 96 94 80 73 66 61 74 82 83 93 95 
24 Kuppu 55 F 95 100 86 66 79 68 70 74 86 72 79 86 
25 Raja 25 M 94 100 86 66 79 68 73 74 86 72 79 86 
 
 
 
 
GROUP F – MEAN ARTERIAL PRESSURE 
S.NO NAME AGE SEX 0 min 5 min 15 min 30 min 45 min 60 min 90 min 120 min 
1 Mani 38 M 84 91 93 76 89 77 100 95 
2 Marimuthu 46 M 95 69 88 69 77 81 97 110 
3 Kesavan 48 M 99 81 87 87 83 84 81 102 
4 Amsavalli 56 F 98 91 85 61 81 89 82 93 
5 Purushothaman 43 M 74 81 73 73 81 81 84 106 
6 Saravanan 39 M 102 86 84 82 93 93 77 81 
7 Arumugam 47 M 97 96 90 83 96 101 96 100 
8 Shanmugam 36 M 102 92 88 86 88 87 79 90 
9 Vadivel 49 M 105 92 93 70 95 95 76 98 
10 George 57 M 99 95 97 85 78 86 73 98 
11 Dhivya 30 F 94 96 83 88 101 101 87 104 
12 Kamal 28 M 98 69 89 74 69 70 92 77 
13 Irfaan 50 M 100 74 91 70 74 82 95 72 
14 Chitra 51 F 81 91 74 71 92 99 96 97 
15 Manickam 52 M 93 76 74 64 76 77 93 88 
16 Vinoth 48 F 102 94 78 75 101 103 83 96 
17 Arunan 43 M 99 89 80 83 89 91 89 91 
18 Jeeva 53 F 89 79 81 69 72 75 85 63 
19 Lakshmi 40 F 82 96 83 75 88 76 77 76 
20 Thilaga 39 F 78 93 76 75 83 77 77 91 
21 Rajesh 34 M 91 74 76 71 73 78 93 74 
22 Sriinivasan 37 M 97 77 92 71 81 71 77 72 
23 Ponnusamy 36 M 105 94 77 77 83 85 69 89 
24 Rajasekar 41 M 101 87 84 79 75 75 81 96 
25 Amudha 40 M 110 81 77 73 77 74 77 77 
 
 
 
 
 
 
 GROUP D – SIDE EFFECTS 
S.NO NAME AGE SEX BRADYCARDIA HYPOTENSION NAUSEA VOMITING DRY MOUTH PRURITUS 
RESPIRATORY 
DEPRESSION 
1 Kathirvel 40 M Yes No No No Yes No No 
2 Muthusamy 45 M No No No No No No No 
3 Kuppan 50 M No No No No No No No 
4 Seetha 35 F No No No No No No No 
5 Ananthi 38 F No No No No No No No 
6 Chinnaraj 38 M No No No No No No No 
7 Savithri 36 F No No No No No No No 
8 Vasantha 40 F No No Yes No Yes No No 
9 Murugesan 45 M No No No No No No No 
10 Pandu 40 M No No No No No No No 
11 Vinoth 22 M No No No No No No No 
12 Murugesan 40 M No No No No No No No 
13 Iyyapan 34 M No No No No No No No 
14 Asairaj 35 F No Yes No No No No No 
15 Malar 32 F No No Yes No No No No 
16 Vinoth 36 M No No No No No No No 
17 Uma rani 37 F No No No No No No No 
18 Manickam 40 M No No No No No No No 
19 Gopal 31 M No No No No No No No 
20 Senthil 55 M No No No No No No No 
21 Ramya 28 F No No No No No No No 
22 Nandagopal 40 M No No No No No No No 
23 Sathyamurthy 50 M No No No No Yes No No 
24 Kuppu 55 F No No No No No No No 
25 Raja 25 M No No No No No No No 
 
 
GROUP F – SIDE EFFECTS 
S.NO NAME AGE SEX BRADYCARDIA HYPOTENSION NAUSEA VOMITING DRY MOUTH PRURITUS 
RESPIRATORY 
DEPRESSION 
1 Mani 38 M No No No No No No No 
2 Marimuthu 46 M No No No No No No No 
3 Kesavan 48 M No No No No No No No 
4 Amsavalli 56 F No No No No No No No 
5 Purushothaman 43 M No No Yes Yes No Yes No 
6 Saravanan 39 M No No No No No No No 
7 Arumugam 47 M No No No No No No No 
8 Shanmugam 36 M No No No No No No No 
9 Vadivel 49 M No No Yes No No No No 
10 George 57 M No No No No No No No 
11 Dhivya 30 F No No No No No No No 
12 Kamal 28 M No No No No No No No 
13 Irfaan 50 M No No Yes Yes No No No 
14 Chitra 51 F No No No No No No No 
15 Manickam 52 M No No No No No No No 
16 Vinoth 48 F No No No No No No No 
17 Arunan 43 M No No No No No No No 
18 Jeeva 53 F No No No No No No No 
19 Lakshmi 40 F No No No No No Yes No 
20 Thilaga 39 F No No No No No No No 
21 Rajesh 34 M No No No No No No No 
22 Sriinivasan 37 M No No No No No No No 
23 Ponnusamy 36 M No No No No No No No 
24 Rajasekar 41 M No No No No No No No 
25 Amudha 40 M No Yes No No No No No 
 
 
 
GROUP D – VISUAL ANALOGUE SCORE  
S.NO NAME AGE SEX 30 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min 
1 Kathirvel 40 M 0 0 0 1 1 2 2 4 
2 Muthusamy 45 M 0 0 0 1 2 2 3 4 
3 Kuppan 50 M 0 1 1 2 2 3 3 4 
4 Seetha 35 F 0 0 0 1 2 2 3 4 
5 Ananthi 38 F 0 0 0 2 2 3 3 4 
6 Chinnaraj 38 M 0 0 0 1 1 2 3 3 
7 Savithri 36 F 0 0 1 1 2 3 3 4 
8 Vasantha 40 F 0 1 1 1 2 2 3 3 
9 Murugesan 45 M 0 1 1 2 2 3 4 4 
10 Pandu 40 M 0 1 1 1 2 2 4 4 
11 Vinoth 22 M 0 1 1 2 2 2 3 4 
12 Murugesan 40 M 0 0 0 1 2 2 3 4 
13 Iyyapan 34 M 0 1 1 2 3 3 3 4 
14 Asairaj 35 F 0 0 0 1 2 2 3 4 
15 Malar 32 F 0 0 1 1 1 2 3 4 
16 Vinoth 36 M 0 0 0 1 1 2 3 4 
17 Uma rani 37 F 0 0 1 1 2 2 3 4 
18 Manickam 40 M 0 0 1 0 1 2 2 4 
19 Gopal 31 M 0 0 1 1 2 2 4 4 
20 Senthil 55 M 0 0 1 2 2 2 4 4 
21 Ramya 28 F 0 1 1 2 2 2 3 4 
22 Nandagopal 40 M 0 0 0 0 1 3 4 4 
23 Sathyamurthy 50 M 0 0 1 2 2 3 4 4 
24 Kuppu 55 F 0 1 1 1 1 3 3 4 
25 Raja 25 M 0 0 0 1 2 2 3 4 
 
 
 
 
GROUP F – VISUAL ANALOGUE SCORE  
S.NO NAME AGE SEX 15 min 30 min 45 min 60 min 90 min 120 min 
1 Mani 38 M 0 2 2 2 2 4 
2 Marimuthu 46 M 0 1 1 2 3 4 
3 Kesavan 48 M 0 1 1 2 2 3 
4 Amsavalli 56 F 0 0 1 2 2 4 
5 Purushothaman 43 M 0 1 1 2 2 3 
6 Saravanan 39 M 0 2 2 3 3 4 
7 Arumugam 47 M 0 1 2 2 3 4 
8 Shanmugam 36 M 0 1 1 2 3 4 
9 Vadivel 49 M 0 1 1 2 2 4 
10 George 57 M 0 2 2 2 2 3 
11 Dhivya 30 F 0 2 2 2 3 4 
12 Kamal 28 M 0 1 1 2 2 4 
13 Irfaan 50 M 0 2 2 2 2 4 
14 Chitra 51 F 0 1 1 3 3 4 
15 Manickam 52 M 0 1 1 2 2 3 
16 Vinoth 48 F 0 2 2 2 3 4 
17 Arunan 43 M 0 2 2 2 3 4 
18 Jeeva 53 F 0 1 1 2 2 4 
19 Lakshmi 40 F 0 0 0 2 2 3 
20 Thilaga 39 F 0 1 1 2 2 4 
21 Rajesh 34 M 0 0 0 2 3 4 
22 Sriinivasan 37 M 0 1 1 2 2 3 
23 Ponnusamy 36 M 0 0 0 1 2 4 
24 Rajasekar 41 M 0 1 1 1 2 4 
25 Amudha 40 M 0 1 1 2 3 4 
 
 
 
 
GROUP D – SEDATION SCORE 
S.NO NAME AGE SEX 15 min 30 min 45 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min 
1 Kathirvel 40 M 3 3 3 3 3 2 2 2 1 1 
2 Muthusamy 45 M 3 3 3 3 3 2 2 2 1 1 
3 Kuppan 50 M 3 3 3 3 3 2 2 1 1 1 
4 Seetha 35 F 3 3 3 3 3 2 2 2 2 1 
5 Ananthi 38 F 3 3 3 3 3 2 2 1 1 1 
6 Chinnaraj 38 M 3 3 3 3 2 3 3 2 2 2 
7 Savithri 36 F 3 3 3 3 2 2 2 1 1 1 
8 Vasantha 40 F 3 3 3 3 2 2 2 2 1 1 
9 Murugesan 45 M 3 2 2 2 2 2 2 1 1 1 
10 Pandu 40 M 3 3 3 3 3 1 2 1 1 1 
11 Vinoth 22 M 3 2 2 2 2 2 1 1 1 1 
12 Murugesan 40 M 3 3 3 2 2 2 2 2 1 1 
13 Iyyapan 34 M 3 3 3 3 3 2 2 1 1 1 
14 Asairaj 35 F 3 3 3 3 3 2 2 1 1 1 
15 Malar 32 F 2 2 2 2 2 2 2 2 1 1 
16 Vinoth 36 M 3 3 3 3 3 2 2 2 1 1 
17 Uma rani 37 F 3 2 2 2 2 2 1 1 1 1 
18 Manickam 40 M 3 3 3 2 2 2 2 2 1 1 
19 Gopal 31 M 3 3 3 2 2 2 2 1 1 1 
20 Senthil 55 M 3 3 3 3 2 2 2 2 1 1 
21 Ramya 28 F 3 3 3 2 2 2 2 1 1 1 
22 Nandagopal 40 M 3 3 3 3 3 2 2 1 1 1 
23 Sathyamurthy 50 M 3 3 3 3 3 2 2 1 1 1 
24 Kuppu 55 F 3 3 3 2 2 2 2 1 1 1 
25 Raja 25 M 3 3 3 2 2 2 2 2 1 1 
 
 
 
 
GROUP F – SEDATION SCORE  
S.NO NAME AGE SEX 15 min 30 min 45 min 60 min 90 min 120 min 
1 Mani 38 M 1 1 1 1 1 1 
2 Marimuthu 46 M 2 1 1 1 1 1 
3 Kesavan 48 M 1 1 1 1 1 1 
4 Amsavalli 56 F 2 1 1 1 1 1 
5 Purushothaman 43 M 1 1 1 1 1 1 
6 Saravanan 39 M 2 1 1 1 1 1 
7 Arumugam 47 M 2 1 1 1 1 1 
8 Shanmugam 36 M 2 1 1 1 1 1 
9 Vadivel 49 M 2 1 1 1 1 1 
10 George 57 M 2 1 1 1 1 1 
11 Dhivya 30 F 2 1 1 1 1 1 
12 Kamal 28 M 2 1 1 1 1 1 
13 Irfaan 50 M 2 1 1 1 1 1 
14 Chitra 51 F 2 2 2 1 1 1 
15 Manickam 52 M 2 2 2 1 1 1 
16 Vinoth 48 F 2 1 1 1 1 1 
17 Arunan 43 M 2 1 1 1 1 1 
18 Jeeva 53 F 2 1 1 1 1 1 
19 Lakshmi 40 F 2 1 1 1 1 1 
20 Thilaga 39 F 2 1 1 1 1 1 
21 Rajesh 34 M 2 2 2 1 1 1 
22 Sriinivasan 37 M 2 1 1 1 1 1 
23 Ponnusamy 36 M 2 1 1 1 1 1 
24 Rajasekar 41 M 2 2 2 1 1 1 
25 Amudha 40 M 2 2 1 1 1 1 
 
 
 
 
GROUP D – RESPIRATORY RATE  
S.NO NAME AGE SEX 15 min 30 min 45 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min 
1 Kathirvel 40 M 16 18 15 16 14 15 15 17 19 17 
2 Muthusamy 45 M 14 16 13 12 14 12 14 17 16 14 
3 Kuppan 50 M 18 17 15 18 17 16 18 20 18 16 
4 Seetha 35 F 14 15 16 16 15 17 15 18 19 15 
5 Ananthi 38 F 16 17 16 18 16 12 15 16 18 15 
6 Chinnaraj 38 M 18 17 15 16 16 15 17 18 19 17 
7 Savithri 36 F 14 16 15 12 13 15 16 14 14 16 
8 Vasantha 40 F 13 15 15 17 14 12 13 15 16 14 
9 Murugesan 45 M 17 15 15 16 17 15 17 18 17 15 
10 Pandu 40 M 15 17 18 16 18 16 16 18 17 18 
11 Vinoth 22 M 14 13 16 15 17 16 18 17 16 15 
12 Murugesan 40 M 15 16 14 18 17 16 17 19 16 18 
13 Iyyapan 34 M 15 15 16 18 16 14 17 18 18 17 
14 Asairaj 35 F 17 16 17 15 18 16 17 18 14 15 
15 Malar 32 F 15 17 16 18 16 17 16 15 17 16 
16 Vinoth 36 M 12 15 16 15 15 17 16 16 14 13 
17 Uma rani 37 F 14 14 13 15 16 13 16 15 14 15 
18 Manickam 40 M 15 17 15 18 14 15 16 18 19 17 
19 Gopal 31 M 16 18 15 16 14 16 14 16 18 19 
20 Senthil 55 M 15 17 18 15 16 14 17 18 16 15 
21 Ramya 28 F 12 13 15 13 12 13 15 16 14 12 
22 Nandagopal 40 M 13 15 13 14 16 11 13 14 17 15 
23 Sathyamurthy 50 M 15 16 14 16 13 17 14 15 16 15 
24 Kuppu 55 F 16 18 16 17 18 20 19 16 17 16 
25 Raja 25 M 14 13 12 11 14 15 14 13 14 15 
 
 
 
 
GROUP F - RESPIRATORY RATE 
S.NO NAME AGE SEX 15 min 30 min 45 min 60 min 90 min 120 min 
1 Mani 38 M 14 16 14 16 15 17 
2 Marimuthu 46 M 16 17 16 14 18 16 
3 Kesavan 48 M 13 14 13 15 13 16 
4 Amsavalli 56 F 14 13 15 13 16 16 
5 Purushothaman 43 M 15 15 14 13 15 16 
6 Saravanan 39 M 13 12 14 13 14 13 
7 Arumugam 47 M 13 15 13 15 14 14 
8 Shanmugam 36 M 14 13 14 15 13 16 
9 Vadivel 49 M 16 17 14 16 18 19 
10 George 57 M 16 15 16 14 16 17 
11 Dhivya 30 F 14 13 14 15 13 15 
12 Kamal 28 M 15 15 14 16 14 15 
13 Irfaan 50 M 16 15 15 17 14 13 
14 Chitra 51 F 15 17 13 14 16 15 
15 Manickam 52 M 16 14 16 14 14 15 
16 Vinoth 48 F 12 15 13 12 11 13 
17 Arunan 43 M 13 12 13 12 15 14 
18 Jeeva 53 F 15 17 14 15 14 16 
19 Lakshmi 40 F 15 14 14 13 15 14 
20 Thilaga 39 F 13 12 13 11 13 15 
21 Rajesh 34 M 12 13 12 14 16 16 
22 Sriinivasan 37 M 13 14 13 16 14 15 
23 Ponnusamy 36 M 13 16 14 13 14 13 
24 Rajasekar 41 M 14 13 12 11 13 15 
25 Amudha 40 M 15 16 14 12 13 14 
 
PROFORMA 
 
“PROSPECTIVE, RANDOMIZED COMPARATIVE 
STUDY ON EFFECTS OF ADDING DEXMEDITOMIDINE 
AND FENTANYL TO EPIDURAL BUPIVACAINE 
(0.125%) ON POST OPERATIVE ANALGESIA IN 
PATIENTS UNDERGOING THORACOTOMY" 
 
Name:                               Age:                    Sex:                        
 
I.P.No:  
 
Diagnosis:                                                                       
 
Surgery Planned:  
 
Preoperative Assessment:  
 
History:  
 
Co-Morbid Illness & Treatment Details:  
 
 Effort Tolerance- _______ Mets 
 H/O Previous Surgery: 
 
GENERAL EXAMINATION:  
Height:       Weight:   BMI:             
Anaemia          Jaundice     
Pulse         BP         CVS          RS          Spine          
INVESTIGATIONS: 
BT:                                                CT:                                 
 
Blood Grouping & Typing: 
 
Blood Sugar:                    Urea:                            
 
Creatinine:   ECG:  CXR:  
PFT: 
 
EPIDURAL CATHETERISATION:  
Position:                      Space:                  Needle:                
Size:                 Median/Paramedian 
 
Induction: 
Proceed with Surgery: 
Study Drug Administration: 
Extubation: 
POST OP VITAL PARAMETERS:  
TIME  HR SBP DBP  MAP SPO2  RR VAS Sedation 
0 min         
5 min         
15 
min 
        
30 
min 
        
45 
min 
        
60 
min 
        
90 
min 
        
120         
min 
180 
min 
        
240 
min 
        
300 
min 
        
360 
min 
        
 
Post OP: 
Rescue Analgesic Time 
 
Side Effects: 
Hypotension                                                                                  
Urinary Retention 
Bradycardia                                                                                   
Respiratory Depression 
Nausea, Vomiting 
Dry Mouth 
 
Drugs: 
INJ. Ephedrine ___ mg     Time: 
INJ. Atropine __ mg       Time: 
 
 
 
 
 
ANTIPLAGARISM SCREEN SHOT 
 
PATIENT INFORMATION FORM 
 
Name of the Investigator:  Dr.M. Thiriloga Sundary 
Name of the Participant:  
 
Title: Prospective randomized comparative study on the 
effects of adding dexmedetomidine and fentanyl to 
epidural bupivacaine (0.125%) on post operative 
analgesia in patients undergoing thoracotomy. 
 
 You are invited to take part in this research study  
conducted in Madras Medical College and Rajiv Gandhi  
Government General Hospital. We have got approval from 
the IEC. You are ask to participate in the study because you  
satisfy the eligibility criteria.  
 
PURPOSE OF RESEARCH 
 We want to compare the safe and efficacy of epidural  
dexmedetomidine and epidural fentanyl when given along 
with bupivacaine for post operative pain relief after 
thorocotomy. 
 These drugs when administered via epidural route 
provide post operative pain relief and also avoid usage of 
other systemic analgesic which might be harmful to you.  
 
STUDY DESIGN 
 Patients will be divided into two groups. 
 At end of surgery 1st group will receive 
dexmedetomidine plus bupivacaine epidurally. 2nd group 
will receive fentanyl plus  bupivacaine epidurally.  
 
 After administering the drug, patient’s heart rate, 
blood pressure, analgesic efficacy of  the drug and several 
other parameters will be monitored.  
 
BENEFITS 
 It has been observed from previous studies that these  
epidurally administered drugs provide good post operative 
pain relief. This reduces usage of other analgesics drugs 
and thereby avoids their side effects.  
 
DISCOMFORTS AND RISKS 
 There might be reduction in heart rate and blood  
pressure. For reduction in heart rate atropine will be given. 
For reduction in blood pressure ephedrine will be given.   
 
 This intervention has been shown to be well tolerated 
as indicated by previous studies. Which group you will be  
assigned to depends entirely on chance and if you do not 
want to participate you will have the alternative of getting 
the standard treatment and your safety is our prime consent.  
 
 
Witness Name         Participants Name  
 
Signature        Signature 
PATIENT CONSENT FORM  
 
Study title: Prospective,   randomized comparative study 
on effect of adding dexmedetomidine and fentanyl to 
epidural bupivacaine (0.125%) on postoperative 
analgesia in patients undergoing   thoracotomy 
procedures.   
                                 
Study centre: Institute of Anaesthesiology and Critical Care  
             Madras Medical College & Govt. General Hospital  
             Chennai - 600003 
 
Participant name:            Age:                         Sex:                                 
I.P.No: 
 
 I confirm that I have understood the purpose of 
procedure for the above study. I have the opportunity to ask 
the question and all my questions and doubts have been 
answered to my satisfaction. 
                      
 I have been explained about the pitfall in the 
procedure. I have been explained about the safety,  
advantage and disadvantage of the technique.  
 
 I understand that my participation in the study is 
voluntary and that I am free to withdraw at anytime without 
giving any reason.  
 
 I understand that investigator,  regulatory authorities 
and the ethics committee will not need my permission to 
look at my health records both in respect to current study 
and any further research that may be conducted in relation 
to it, even if I withdraw from the study. I understand that 
my identity will not be revealed in any information released 
to third parties or published, unless as required under the 
law. I agree not to restrict the use of any data or results that 
arise from the study. 
 
Time:          
 
Date:                                                                                              
Signature / Thumb impression of patient  
 
Place:                                                                                             
 
Patient name: 
 
Signature of the investigator:  
 
Name of the investigator:  
 
 
 
